NameEurope Sessions PDF version Wednesday, 23 October 10:00 e-poster session day 110:00 to 19:20Digital kioskse-poster session 11:50 Advances in drug treatment11:50 to 13:20Auditorium IIOral presentation sessionAdvancing addiction research: global perspectives and collaborative initiatives11:50 to 13:20Auditorium VIOral presentation sessionLives at risk: mental health and substance use11:50 to 13:20Auditorium VIIOral presentation sessionPrevalence of opioids and related harms11:50 to 13:20Auditorium VIIIOral presentation sessionGambling: work-related, financial, and criminological issues11:50 to 13:20Room 5BOral presentation sessionBuilding addiction workforce capacity11:50 to 13:20Room 5COral presentation sessionSupport for recovery11:50 to 13:20Room 1.07Short communication sessionClosed sessionECR Programme — Scientific writing11:50 to 13:20Room 1.10WorkshopEvaluation of drug consumption rooms: guidance step by step11:50 to 13:20Room 1.15Workshop 14:20 Neuroscience and cognition14:20 to 15:50Auditorium IIIShort communication sessionLegal shifts and their Impact on drug use and sentencing14:20 to 15:50Auditorium IVOral presentation sessionDrug policy and the criminal legal system14:20 to 15:50Auditorium VIOral presentation sessionGender and substance use14:20 to 15:50Auditorium VIIIOral presentation sessionSubstance use interventions in youth14:20 to 15:50Room 5AOral presentation sessionMeetings the needs of women who use drugs or alcohol14:20 to 15:50Room 1.06Short communication sessionMethods and measurement14:20 to 15:50Room 1.08Short communication session 16:00 Challenges in community-based prevention16:00 to 17:30Auditorium IMajor sessionThe recovery journey16:00 to 17:30Auditorium IIIOral presentation sessionInfectious diseases in people who inject drugs16:00 to 17:30Auditorium IVOral presentation sessionMeasuring drug market phenomenon16:00 to 17:30Auditorium VIOral presentation sessionSubstance use and psychosis16:00 to 17:30Auditorium VIIOral presentation sessionSurveillance of drug-related morbidity and mortality16:00 to 17:30Room 5AOral presentation sessionInequalities and needs of migrant groups16:00 to 17:30Room 5COral presentation sessionResponses to behavioural addictions16:00 to 17:30Room 1.05Short communication sessionProblematic gambling and gaming16:00 to 17:30Room 1.07Short communication sessionConceptualising health and harms16:00 to 17:30Room 1.08Short communication session 17:50 NPS: trends, concerns and response strategies17:50 to 19:20Auditorium IIIOral presentation sessionDrug use trends17:50 to 19:20Auditorium IVOral presentation sessionUnderstanding interrelationships: mental health and substance use17:50 to 19:20Auditorium VIIOral presentation sessionPsychedelics 117:50 to 19:20Auditorium VIIIOral presentation sessionOpioid treatment 117:50 to 19:20Room 5BOral presentation sessionMotivations for use17:50 to 19:20Room 5COral presentation sessionHepatitis C, HIV, and other drug related harms17:50 to 19:20Room 1.05Short communication sessionOpioids: trends, use and treatments17:50 to 19:20Room 1.06Short communication session 19:30 Why are we not doing better at reducing drug-related deaths?19:30 to 20:30Auditorium IBig debate Thursday, 24 October 10:00 Expert knowledge elicitation to complement and enhance data collection and monitoring efforts.10:00 to 11:30Room 1.10WorkshopWorkshop on conducting drug research in prison: Challenges and key recommendations from the European experience10:00 to 11:30Room 1.15Workshop 11:50 Opioid treatment 211:50 to 13:20Auditorium IIIOral presentation sessionOpioid Agonist Treatment: novel formulations and challenges11:50 to 13:20Auditorium IVOral presentation sessionEvidence informed drug and alcohol policy11:50 to 13:20Auditorium VIOral presentation sessionEmerging drug harms, DCRs and other responses11:50 to 13:20Auditorium VIIShort communication sessionInnovative methods for understanding drug markets and policy11:50 to 13:20Room 5AOral presentation sessionWorkers reaching marginalised groups11:50 to 13:20Room 5COral presentation sessionChallenges, threats, and opportunities in addiction publishing today11:50 to 13:20Room 1.05Oral presentation sessionEU research funding opportunities11:50 to 13:20Room 1.07WorkshopContemporary issues11:50 to 13:20Room 1.08Oral presentation session 14:20 Novel neurobiology - cannabis, cognition and craving14:20 to 15:50Auditorium IIIOral presentation sessionUnderstanding drug-related deaths14:20 to 15:50Auditorium IVOral presentation sessionYoung people, mental health and substance use14:20 to 15:50Auditorium VIIOral presentation sessionPregnancy, drug use and care14:20 to 15:50Room 5BOral presentation sessionCo-creating robust systems with workers14:20 to 15:50Room 5COral presentation sessionUnderstanding harm reduction: economic, social, and health perspectives14:20 to 15:50Room 1.05Short communication sessionEuropean prevention curriculum: increasing the use of evidence-based prevention14:20 to 15:50Room 1.06Short communication sessionWomen's realities of drug use14:20 to 15:50Room 1.08Oral presentation sessionScenarios for the future of addictions fields by 204014:20 to 15:50Room 1.10WorkshopWriting for 'addiction' journals for early career researchers with DEPP Editors-in-Chief14:20 to 15:50Room 1.15Workshop 16:00 NPS: Pharmacological Characterization and Substance Analysis16:00 to 17:30Auditorium IIIOral presentation sessionCannabis legalisation — models and impacts16:00 to 17:30Auditorium VIOral presentation sessionProtective and risk factors in drug prevention16:00 to 17:30Room 5AOral presentation sessionPolicy issues in gambling16:00 to 17:30Room 5BOral presentation sessionCity insights: creating a collaborative network for city-level monitoring of drug trends and harm reduction16:00 to 17:30Room 1.07WorkshopHow to respond to real-time drug alerts in European countries ?16:00 to 17:30Room 1.15Workshop 17:50 Mixed methods for understanding drug use17:50 to 19:20Auditorium IIIOral presentation sessionViral hepatitis among people who inject drugs17:50 to 19:20Auditorium IVOral presentation sessionSubstance use and mental health in treatment settings17:50 to 19:20Auditorium VIIOral presentation sessionMisuse of medicines17:50 to 19:20Auditorium VIIIOral presentation sessionFrom old to new: changes in drug use17:50 to 19:20Room 5COral presentation sessionNewly Regulated Markets, Managing Harms, Treatment & Advocating for Reform17:50 to 19:20Room 1.06Short communication sessionInternet, smartphones and social media use17:50 to 19:20Room 1.07Short communication session Friday, 25 October 10:00 A comparative discussion on the role, challenges, and opportunities for addiction nurses within Europe10:00 to 11:30Room 1.15Workshop 11:50 The ripple effect: International developments in the opioid market and their potential implications for European public health and security11:50 to 13:20Auditorium IMajor sessionGaming and social media use11:50 to 13:20Auditorium IIIOral presentation sessionIntentional and non-intentional drug-related deaths11:50 to 13:20Auditorium IVOral presentation sessionPsychedelics 211:50 to 13:20Auditorium VIOral presentation sessionUnravelling the nexus: understanding drug-related violence across Europe11:50 to 13:20Auditorium VIIIOral presentation sessionOnline monitoring11:50 to 13:20Room 5BOral presentation sessionSubstance use and treatment needs across European prisons11:50 to 13:20Room 5COral presentation sessionEmerging challenges in drug markets: monitoring, measurement & impacts11:50 to 13:20Room 1.05Short communication sessionGaming and health11:50 to 13:20Room 1.06Short communication sessionSupport for the addiction workforce11:50 to 13:20Room 1.07Oral presentation sessionHow can cannabis policy goals inform the development of evaluation indicators?11:50 to 13:20Room 1.08Workshop 14:20 Alcohol and other drug policies in the work setting – a perspective on European developments14:20 to 15:50Auditorium IIOral presentation sessionOverdose prevention14:20 to 15:50Auditorium IVOral presentation sessionAddressing diverse treatment needs14:20 to 15:50Auditorium VIOral presentation sessionSubstance use and mental health in prison settings14:20 to 15:50Auditorium VIIOral presentation sessionRegulating cannabis supply policies in Europe: navigating the long road to change14:20 to 15:50Auditorium VIIIOral presentation sessionPrevention and addiction in underrepresented groups14:20 to 15:50Room 5AOral presentation sessionImpact of drug policy on drug production & markets14:20 to 15:50Room 5BOral presentation sessionFuture of opioid markets in Europe: Foresight approaches14:20 to 15:50Room 1.10Workshop Presentations Wed 23 Oct 10:00 e-poster"How generational transmissions can shape life?" Evaluation of a genogram group therapy for people with ACoA syndrome 10:00 to 19:20 Digital kiosks Katarzyna Iwanickae-poster"Make the difference" - Qualifying professionals working with families with addiction issues 10:00 to 19:20 Digital kiosks Rebekka Kleinate-poster"Pictures (and Drugs) at an exibition" 10:00 to 19:20 Digital kiosks Patrizio Lamonacae-poster"Supersavers" manages large proportion of opioid overdoses – 5-year follow-up of a regional naloxone program, Sweden 10:00 to 19:20 Digital kiosks Katja Troberge-poster30 years of New Psychoactive Substances (NPS) in Europe. A first integrated public health assessment. 10:00 to 19:20 Digital kiosks Julian Vicentee-posterA business of supplying harm reduction : a necessary evil? 10:00 to 19:20 Digital kiosks François Destombee-posterA digital approach to peer led recovery and social connection to address substance use/and or mental health challenges 10:00 to 19:20 Digital kiosks Susan Barnese-posterA feasibility and tolerability study of home-use tDCS in patients with substance use disorders (SUD) 10:00 to 19:20 Digital kiosks Laia Miquele-posterA Look at Non-Compliance: Examining Alcohol Industry Marketing Practices in Portugal 10:00 to 19:20 Digital kiosks Hilson Cunha Filhoe-posterA narrative review of nurse-led addiction models of care; informing the foundations for international nursing. 10:00 to 19:20 Digital kiosks Sadie Lavelle Cafferkeye-posterA National Survey of Alcohol Care Teams (ACTs) in England: Characteristics of Patients and Components of Care 10:00 to 19:20 Digital kiosks Philippa Casee-posterA Prospective Study: Patterns and Trends in Opioid Use and Treatment with Focus on Older Populations 10:00 to 19:20 Digital kiosks Jo-Hanna Iverse-posterA systematic review of second-hand smoking mass media campaigns (2002-2022) 10:00 to 19:20 Digital kiosks Carmen Lime-posterActivities and Experiences of Czech Adolescents in Cyberspace 10:00 to 19:20 Digital kiosks Martin Dolejše-posterAcute and Chronic Effects of Cannabis on the Neural Correlates of Working Memory in Adolescents versus Adults 10:00 to 19:20 Digital kiosks Sorcha Hamiltone-posterAddiction, a volitional disorder. 10:00 to 19:20 Digital kiosks Nicolas Figueirede-posterAddiction-related dreams: Interpretative Phenomenological Analysis of content and recovery from addiction 10:00 to 19:20 Digital kiosks Shawn Rutledgee-posterAddictive Behaviours Workforce development: from global to European higher education programs 10:00 to 19:20 Digital kiosks Olatz López Fernándeze-posterADDIRIS - Addiction and Harm Reduction: a global French-speaking network for online learning 10:00 to 19:20 Digital kiosks Romain Bache-posterAdherence to Opioid Use Disorder treatment with an extended-release weekly and monthly injectable buprenorphine 10:00 to 19:20 Digital kiosks Michael Froste-posterAdvancing Addiction Interventions: Porto's Comprehensive Approach in the Municipal Health Plan 10:00 to 19:20 Digital kiosks Paula Pinto Oliveirae-posterAdverse childhood experiences, adult attachment and parenting styles in a population with addictive behaviors 10:00 to 19:20 Digital kiosks Teodomiro Pirese-posterAgeing in the context of the Opioid Maintenance Treatment in Portugal: Impact of public health policies on ageing users 10:00 to 19:20 Digital kiosks Lara Queiroz Sampaioe-posterAlcohol use across trials of psychological interventions for bipolar: A systematic review and meta-analysis 10:00 to 19:20 Digital kiosks Lauren Halsalle-posterAlcohol, Driving and Crime - Health Care and Justice: An Outreach Intervention 10:00 to 19:20 Digital kiosks Celestino Cunhae-posterAlcohol, transitions and communities of belonging within marginalised groups – towards a model of understanding. 10:00 to 19:20 Digital kiosks Peter Nelsone-posterAn audit of patient’s Health / Social Care needs referred to a Dual Diagnosis Social Care pathway in Ireland 10:00 to 19:20 Digital kiosks Aidan Cooneye-posterAn evaluation of “harm reduction” outreach service evaluative research in Macau 10:00 to 19:20 Digital kiosks Augusto Nogueirae-posterAnabolic steroid use and use of other image- and performance-enhancing drugs on the rise – A new substance use disorder 10:00 to 19:20 Digital kiosks Raphael Magnolinie-posterAnalysis of the satisfaction survey results of users of the Mobile Drug Consumption Room Program in Lisbon 10:00 to 19:20 Digital kiosks Adriana Almeidae-posterAnxiety, Depression, Stress, and Self-Harm in relation to Gaming Disorder: A Longitudinal Study of Czech Adolescents 10:00 to 19:20 Digital kiosks Jaroslava Sucháe-posterApplied health research in alcohol-related liver disease: a rapid qualitative inquiry with healthcare providers 10:00 to 19:20 Digital kiosks Sofia Hemragee-posterApplying foresight research for drug policy: Lessons from the DRUG-PREP project 10:00 to 19:20 Digital kiosks Bert Hauspiee-posterAre Patients with Schizophrenia Reliably Reporting their Cannabis Use? An African Cross-sectional Study 10:00 to 19:20 Digital kiosks Said Boujrafe-posterAssessing Food Security and Hunger in Heroin-Assisted Treatment (HAT) Participants: Insights from Norway's HAT Project 10:00 to 19:20 Digital kiosks Omid Dadrase-posterAssessing hindering and facilitating factors of help-seeking behaviour in cannabis use: descriptive qualitative study 10:00 to 19:20 Digital kiosks Laura Väätäinene-posterAssessing progress towards viral hepatitis B and C elimination in prison settings in the European region 10:00 to 19:20 Digital kiosks Riccardo Pisettae-posterAssessing the prevalence of problem gambling among the Slovenian population 10:00 to 19:20 Digital kiosks Špela Selake-posterAssessing Therapeutic Alliance: A Pilot Study Measuring Therapeutic Alliance and It's Impact on Patient Outcomes 10:00 to 19:20 Digital kiosks Siobhan Morsee-posterAssociation between slot machine gambling and debt recovery process-Finnish population-based study with register linkage 10:00 to 19:20 Digital kiosks Tiina Latvalae-posterBalancing between care and control - staff perception on the introduction of new medication for opioid agonist treatment 10:00 to 19:20 Digital kiosks Andrea Johansson Capusane-posterBarriers to Substance Use Treatment as Perceived by Professionals and Arabic Refugees in Germany 10:00 to 19:20 Digital kiosks Ebtesam Salehe-posterBenefits of a Yoga intervention in portuguese female inmates: preliminary results 10:00 to 19:20 Digital kiosks Andreia Nisae-posterBuilding Capacity for Social Return on Investment Analysis of Supervised Consumption Services in Saskatoon SK, Canada 10:00 to 19:20 Digital kiosks Barbara Fornsslere-posterBuprenorphine prescription patterns at a tertiary care hospital in northern India: A retrospective chart review 10:00 to 19:20 Digital kiosks Abhishek Guptae-posterBurden of disease due to drug use disorders in the European Union: analysis of 1990-2019 trends and patterns 10:00 to 19:20 Digital kiosks Vera Pinheiroe-posterBurnout and Engagement in Addictive Behaviors and Dependencies HCWs at Portuguese North Region: an epidemiological study 10:00 to 19:20 Digital kiosks Cátia Coutinhoe-posterCan we prevent the misuse of prescription stimulants? : a case report 10:00 to 19:20 Digital kiosks Ivana Todorić Laidlawe-posterCannabis use and its link to psychopathological and functional outcomes: Insights from self-reports and hair data 10:00 to 19:20 Digital kiosks Lydia Johnson-Fergusone-posterCannabis use and severity of cannabis dependence among Georgian small-scale cannabis growers in 2021 10:00 to 19:20 Digital kiosks Tamari Mgebrishvilie-posterCannabis use and withdrawal and escalation to psychiatric intensive care 10:00 to 19:20 Digital kiosks Edward Chesneye-posterCaring with Care: VITAE’s integrative and therapeutic model towards socially vulnerable individuals 10:00 to 19:20 Digital kiosks Brenda Sousa da Silvae-posterCase Series: Prospective Study on the Efficacy of Pregabalin in Managing Opioid Withdrawal Syndrome 10:00 to 19:20 Digital kiosks Sofia Golbreiche-posterCatalysts for Change: Youth-Driven Insights in Opioid Harm Reduction 10:00 to 19:20 Digital kiosks Rebeca Calzadae-posterChallenges and needs of Cologne's open drug scene: insights from a quantitative study on Neumarkt square 10:00 to 19:20 Digital kiosks Daniel Deimele-posterChallenges in the management of skin and soft tissue infections among people who inject drugs in Athens, Greece. 10:00 to 19:20 Digital kiosks Apostolia Fragkoulie-posterChanges in self-reported alcohol use post absolute alcohol sales bans: the case of Botswana during COVID pandemic. 10:00 to 19:20 Digital kiosks J. Maphisa Maphisae-posterCharacterising South Africa’s drug markets with people who sell heroin, methamphetamine and cocaine 10:00 to 19:20 Digital kiosks MJ Stowee-posterChemsex: An Umbrella Review 10:00 to 19:20 Digital kiosks Liam Johnstonee-posterCombination non-medical use of gabapentin and medications for opioid use disorder: A qualitative study 10:00 to 19:20 Digital kiosks Mance Buttrame-posterCommon mental disorders in prisoners with childhood trauma and substance use; the role of emotion regulation 10:00 to 19:20 Digital kiosks Faridah Nakomae-posterCommunity led networking and advocacy for the elimination of discrimination of women who use drugs in Europe 10:00 to 19:20 Digital kiosks Ligia Parodie-posterComorbid bloodborne diseases among people with opioid use disorders on medication-assisted treatment in Tanzania. 10:00 to 19:20 Digital kiosks Dorothy Mushie-posterCOMPARED RETENTION RATES BETWEEN PATIENTS TREATED WITH BUVIDAL IN FRANCE vs. SUBLINGUAL BUPRENORPHINE (OPALE-2 STUDY) 10:00 to 19:20 Digital kiosks Alice Deschenaue-posterComparison of HOMA-IR, Tg/Glucose Index and Tg/HDL-C ratio for predicating MetSy in HCV seronegative heroin dependents 10:00 to 19:20 Digital kiosks Zanina Perevska e-posterComplicated Alcohol Withdrawal Syndrome: retrospective study of an inpatient alcohol treatment unit 10:00 to 19:20 Digital kiosks Ines Pereirae-posterComunicAr’te - Communicating through Art in Group Therapy on Addictive Behaviors 10:00 to 19:20 Digital kiosks Carla Matiase-posterConceptual competence in addiction: integrative contributions from philosophical and theoretical work in psychiatry 10:00 to 19:20 Digital kiosks Carl Erik Fishere-posterContribution of the workforce to retention of clients in Kombani Medically Assisted Therapy (MAT) in Kwale, Kenya. 10:00 to 19:20 Digital kiosks Esther Mumoe-posterCortical thickness and brain aging in individuals engaging in unhealthy alcohol use 10:00 to 19:20 Digital kiosks Marco Hermesdorfe-posterCOVID-19 and earthquakes-related stress, quality of life, mental health, and internet-based addictive behaviour 10:00 to 19:20 Digital kiosks Tina Peraicae-posterCrack cocaine use, street life and migrant population. An Italian observatory by ItaRdd, Cnca, Forum Droghe. 10:00 to 19:20 Digital kiosks Luca Censie-posterCritical assessment of the role of compulsory treatment of drug use disorders in Germany 10:00 to 19:20 Digital kiosks Ingo Ilja Michelse-posterDCR in Paris : a constant experiment 10:00 to 19:20 Digital kiosks Victor Detreze-posterDegree of smartphone addiction in the university environment 10:00 to 19:20 Digital kiosks Raul Vernete-posterDeveloping a Toolkit for health care professionals working with Pregnant People who use Drugs in Southern Africa 10:00 to 19:20 Digital kiosks Julie-Anne Mac Donnelle-posterDeveloping practical tools for identifying and supporting treatment-relevant cognitive dys/functions 10:00 to 19:20 Digital kiosks Maria Bravo Aguilerae-posterDevelopment of complementary information to drug-related deaths statistics in Slovenia 10:00 to 19:20 Digital kiosks Mateja Jandle-posterDoping Prevention among Recreational Athletes and the Role of the Police 10:00 to 19:20 Digital kiosks Tobias Elgáne-posterDrug checking via Syringe Vending Machines 10:00 to 19:20 Digital kiosks Mariam Sheroziae-posterDrug-Facilitated Sexual Assaults involving GHB and GBL in Europe – recent evidence and a need for better monitoring. 10:00 to 19:20 Digital kiosks María Flores Lópeze-posterDrug-Related Deaths following Bariatric surgery: Case Series Report 10:00 to 19:20 Digital kiosks Eman Msharie-posterDUDIT-E Brazilian Adaptation and TrIE-AD Application Development: A Intervention Approach for Young Drug Users 10:00 to 19:20 Digital kiosks Richard Alecsander Reicherte-posterEffectiveness of the brief intervention for methamphetamine users in Poland 10:00 to 19:20 Digital kiosks Magdalena Rowickae-posterEffects of a universal school based alcohol prevention intervention 10:00 to 19:20 Digital kiosks Bert Hauspiee-posterEffects of oxytocin and nicotine addiction on psychosocial stress: an fMRI study 10:00 to 19:20 Digital kiosks Jiecheng Rene-posterEfficacy of a digital intervention to reduce or stop cannabis use : study protocol for a randomized controlled trial 10:00 to 19:20 Digital kiosks Emmanuel Lahaiee-posterElectroencephalographic indices of stages of reward memory and implications for therapeutic memory reconsolidation 10:00 to 19:20 Digital kiosks Shelan Oforie-posterElectronic cigarettes use among secondary school students in Slovenia 10:00 to 19:20 Digital kiosks Helena Koprivnikare-posterEmpowering higher education teachers using tripartite drug awareness training model to support youth well-being 10:00 to 19:20 Digital kiosks Munir Sewanie-posterEnhanced Alcohol-Specific Pavlovian-to-Instrumental Transfer in Alcohol Use Disorder 10:00 to 19:20 Digital kiosks Michael Smolkae-posterEnhancing HIV Self-Testing Uptake through Syringe Vending Machines: A Case Study in Tbilisi, Georgia 10:00 to 19:20 Digital kiosks Irma Kirtadzee-posterEnrichment of Prevention Methodologies with Self Help/Mutual aid practices: The case of the Centre of Prevention Greece 10:00 to 19:20 Digital kiosks Sotiris Lainase-posterEstimation of prevalence (and patterns) of cannabis use from various data sources 10:00 to 19:20 Digital kiosks Darja Lavtare-posterEthical considerations of responsible gambling in metaverse 10:00 to 19:20 Digital kiosks Susanne Uusitaloe-posterEvaluation of a UK Bristol capillary blood service for blood-borne virus detection to reach HCV elimination targets 10:00 to 19:20 Digital kiosks Stephanie Hutchingse-posterEvaluation of inpatient conversion from high dose methadone to long-acting injectable buprenorphine (LAIB) 10:00 to 19:20 Digital kiosks Stuart Fishere-posterEvaluation of participants' experiences enrolled in a community-based mobile withdrawal management service 10:00 to 19:20 Digital kiosks Andrew Lodgee-posterExperiences of female substance users with trauma-sensitive yoga as complementary support in addiction treatment 10:00 to 19:20 Digital kiosks Julie Schampe-posterExperiences with Xylazine among Residential Treatment Patients 10:00 to 19:20 Digital kiosks Courtney Nordecke-posterExploring Cultural Dynamics of Black Asian Ethnic Women in Addiction Recovery 10:00 to 19:20 Digital kiosks Shinasa Shahide-posterExploring Diverse Applications of Multicriteria Decision Analysis in Drug Policy: A Comprehensive Overview. 10:00 to 19:20 Digital kiosks Nicola Worcmane-posterExploring dual diagnosis in opioid agonist treatment: A comparative study between the Czech Republic and Norway 10:00 to 19:20 Digital kiosks Svetlana Skurtveite-posterExploring the gendered impact on women of the impact of the changes in commissioning in drug and alcohol services. 10:00 to 19:20 Digital kiosks Victoria Beeree-posterExploring the role of gender on treatment outcomes in older adults with alcohol use disorder 10:00 to 19:20 Digital kiosks Jeppe Tryggedssone-posterFeatures and correlates of Internet Gaming Disorder in women and men who play video games: a cross-national study 10:00 to 19:20 Digital kiosks Caitlin McClure-Thomase-posterFentanyl among adolescent in Poland - the scale of the phenomenon and preventive actions 10:00 to 19:20 Digital kiosks Ewelina Silecka-Mareke-posterForgotten children - losses of children growing up with addicted parents 10:00 to 19:20 Digital kiosks Szilvia Kassaie-posterFraming alcohol policies in non-prohibitionist States: An existentialist dilemma? 10:00 to 19:20 Digital kiosks Subrata Biswase-posterFrequency of cannabis and amphetamine use past month in patients on opioid maintenance treatment with buprenorphine 10:00 to 19:20 Digital kiosks Natasha Simonovskae-posterFrom intrusive memory to craving in cocaine use disorder – An ecological momentary assessment study 10:00 to 19:20 Digital kiosks Amelie Zachere-posterGender violence experienced by women who use drugs 10:00 to 19:20 Digital kiosks Ana Isabel Ibar-Fañanáse-posterGenerative AI to support Harm Reduction 10:00 to 19:20 Digital kiosks Angus Bancrofte-posterGlobal trends and Challenges of the Drug Phenomenon in Central Asia 10:00 to 19:20 Digital kiosks Ernest Robelloe-posterGratitude amidst unease: Interviews with Swedish forensic psychiatric male patients with substance use disorder 10:00 to 19:20 Digital kiosks Charlotta Svenssone-posterHarm Reduction: A Pathway To Community Health in Nigeria 10:00 to 19:20 Digital kiosks Fatima Abiola Popoolae-posterHCV screening in the treatment centers for people with addictions: lessons learned 10:00 to 19:20 Digital kiosks Federica Mathise-posterHepatitis C and pharmaceutical multinationals. An approach to the case of Basque Country (Spain) in 2014/2015 10:00 to 19:20 Digital kiosks Unai Perez de San Roman Landae-posterHigh and repeated use of MDPV induce chronic psychosis in patients with no psychiatric history 10:00 to 19:20 Digital kiosks Andrea Anastasie-posterHIV among people who inject drugs in Stockholm - prevalence, incidence and treatment outcomes 10:00 to 19:20 Digital kiosks Martin Kåberge-posterHospitalizations due to the use of psychoactive substances in Portugal: Impact assessment of the 2008 economic crisis 10:00 to 19:20 Digital kiosks Joana Silvae-posterHybrid skills transfer of the unplugged prevention programme in a French high school abroad (Lisbon, Portugal 2023 2024) 10:00 to 19:20 Digital kiosks Marion Fale-posterIdentification and treatment of alcohol use disorder with the 15-method – implementation in psychiatric care 10:00 to 19:20 Digital kiosks Jennie Sundbyee-posterIf you don't know where you're going, why insist on running - A reflection on the lack of data on dropout... 10:00 to 19:20 Digital kiosks Sofia Freitase-posterImage and performance enhancing drugs among gym and fitness visitors in Slovenia – preliminary results 10:00 to 19:20 Digital kiosks Julijana Zucchiati Godinae-posterImpact of Adherence to the Opioid Substitution Program on Social Determinants of Health in the West Zone of Porto 10:00 to 19:20 Digital kiosks Isabel Pontee-posterImpact of first cardiovascular event versus consecutive episodes on tobacco and alcohol use: a comprehensive analysis 10:00 to 19:20 Digital kiosks Maria Teresa Ponse-posterImpact of fruit smoothie supplementation on psychological distress in patients undergoing opioid agonist therapy 10:00 to 19:20 Digital kiosks Elaheh Javadi Arjmande-posterImpact of the Decriminalization on Drug Use Experiences and Related Risks among People Who Use Drugs in British Columbia 10:00 to 19:20 Digital kiosks Cayley Russelle-posterImplementation of a subject on the care of addiction in the Nursing degree: origin of the need and expectations. 10:00 to 19:20 Digital kiosks Sheimah El Beijjaji Bouzbitae-posterImplementation of two transdiagnostic psychological interventions for alcohol use: Study protocol, preliminary results 10:00 to 19:20 Digital kiosks Alba Abanadese-posterImproving the diagnosis and clinical outcomes on drug addict patients through quantitative spectrometer testing. 10:00 to 19:20 Digital kiosks Teodora Ciolompeae-posterIn search of protective factors against burnout in Addictive Behaviors and Dependencies HCWs at Portuguese North Region 10:00 to 19:20 Digital kiosks Rui Tinocoe-posterIN VITRO INHIBITORY POTENTIAL OF CLASSIC HALLUCINOGENS LSD, 5-MEO-DMT AND MESCALINE OVER CYTOCHROME P450 ENZYMES 10:00 to 19:20 Digital kiosks Mariana Carvalhoe-posterInpatient ketamine detoxification, characterization of a treatment-seeking population with complex needs 10:00 to 19:20 Digital kiosks Osunwale Onie-posterIntegrating Seven Challenges Mastery Counselling and Trauma Informed Care in adolescent substance use interventions. 10:00 to 19:20 Digital kiosks Daniel Merciecae-posterIntervention methods for the psychological problems faced by the wives of individuals with substance use disorders. 10:00 to 19:20 Digital kiosks Ranasinghe Mudiyanselage Sanjeewani Senevirathnee-posterInvestigating the relationship between defense styles and treatment motivation of Turkish males with alcohol use problem 10:00 to 19:20 Digital kiosks Fatmatüz Zehra Pehlivane-posterInvestigating the Relationship Between Stigma and Relapse in IDUs with HIV/AIDS in Pakistan 10:00 to 19:20 Digital kiosks Jawwad Muhammad Shujaate-posterIs addiction a brain-disease? An overview of the evidence 10:00 to 19:20 Digital kiosks Chrysanthi Blithikiotie-posterIs Decriminalising drugs enough? Navigating alternatives to prohibitionism 10:00 to 19:20 Digital kiosks Jorge Quintase-posterIs Integrating Online Stop Smoking Support to Existing Online Talking Therapy Support Feasible? 10:00 to 19:20 Digital kiosks Pamela Jacobsene-posterItalian teenagers’ perceived exposure to Digital Alcohol Marketing 10:00 to 19:20 Digital kiosks Franca Beccariae-posterItalian Validation of Assessment of Recovery Capital Scale in Clinical Population with Alcohol and Drugs Use Disorder 10:00 to 19:20 Digital kiosks Teo Vignolie-posterLeveraging AI to supercharge the training and support of extended workforce in addiction services 10:00 to 19:20 Digital kiosks Christina Todorovae-posterLGBTQIA2S+ perspectives on problem gambling among their peers: Preliminary results of semi-structured interviews 10:00 to 19:20 Digital kiosks Anne-Marie Augere-posterLife Entrapment or Trampoline? Understanding life experiences of rejected asylum seekers in Copenhagen’s open drug scene 10:00 to 19:20 Digital kiosks Arash Setoodehe-posterLived/Living experiences: the potential for integrative collaborations 10:00 to 19:20 Digital kiosks Mary Beth Zenie-posterLong-term Effects of the STAD-model: A Multi-Component Responsible Beverage Service Intervention 10:00 to 19:20 Digital kiosks Johanna Gripenberge-posterLong-Term Outcomes of Substance Use Treatment: A 20-Year Follow-Up Study in the Swedish Addiction Treatment System 10:00 to 19:20 Digital kiosks Tove Sohlberge-posterLove Addiction: Trait Impulsivity, Emotional Dysregulation and Attachment Style 10:00 to 19:20 Digital kiosks Jessica Dineene-posterMaking Hep C treatment more accessible for addictions patients in Belfast 10:00 to 19:20 Digital kiosks Andrew Teeneye-posterMania a Potu: Review of the literature 10:00 to 19:20 Digital kiosks Ines Valadae-posterMapping drug users’ spaces of fear in Cologne, Germany 10:00 to 19:20 Digital kiosks Bo Tackenberge-posterMapping psychedelic retreats and other practices in the EU 10:00 to 19:20 Digital kiosks Tereza Černíkováe-posterMeaning and Self-control in Alcohol Use and Internalizing Symptoms: Causal Insights from (Non)clinical Populations 10:00 to 19:20 Digital kiosks Marcel Näthere-posterMedicinal use of non-prescribed cannabis: motives for use, perceived effectiveness and barriers to treatment (MEDUSA) 10:00 to 19:20 Digital kiosks Lisa Stradae-posterMortality among long-term prescription opioid users 10:00 to 19:20 Digital kiosks Gabriela Rolováe-posterMortality Rates and cause-specific mortality in Patients with Substance-Induced Psychosis 10:00 to 19:20 Digital kiosks Pihla Sassie-posterNavigating cannabis access in zurich: A road safety perspective from early observations of the 'Züri Can' study 10:00 to 19:20 Digital kiosks Patricia Dürlere-posterNegative affectivity, mania, and defense mechanisms in compulsive online buying-shopping disorder 10:00 to 19:20 Digital kiosks Marina Cosenzae-posterNeurocognitive Impulsivity in Opiate Users at Different Lengths of Abstinence 10:00 to 19:20 Digital kiosks Elena Psederskae-posterNew criminal legal strategies towards a more effective inmate treatment (The KETHEA PROMITHEAS project) 10:00 to 19:20 Digital kiosks Apostolos Tsirgoulase-posterNightlife recreational contexts in Viseu: sexism, sexual violence and potential associations with substance use 10:00 to 19:20 Digital kiosks Inês Miguel Rodrigues Armelime-posterNo alcohol at night – Polish experiences 10:00 to 19:20 Digital kiosks Marta Zin-Sedeke-posterOffspring of individuals with alcohol use disorders and professionals in addiction counseling: A qualitative study 10:00 to 19:20 Digital kiosks Fran Calvoe-posterOniomania: a case study according to the differential diagnosis 10:00 to 19:20 Digital kiosks Sofia Nunese-posterOniomania: what is known today? 10:00 to 19:20 Digital kiosks Margarida Duartee-posterOnline gambling and betting in India and their adverse psychological and social complications: A comprehensive review 10:00 to 19:20 Digital kiosks Shyam Sundar Kanagarajane-posterOnline gambling and Loneliness: A State of Knowledge. 10:00 to 19:20 Digital kiosks Volanirina Rasolofomamonjye-posterOpiate-Dependent Service Users knowledge and attitudes towards Supervised Injecting Facilities 10:00 to 19:20 Digital kiosks Annika Gibbonse-posterOptimizing Overdose Response in the Emergency Department: New challenges and initiatives in Scotland 10:00 to 19:20 Digital kiosks Lisa Schöline-posterOUTCAST REGISTRATION: an archive of imprisoned female drug users' biographies 10:00 to 19:20 Digital kiosks Ulrike Möntmanne-posterPackaging of disposable vaping products and e-liquids in England, Canada, and the United States: a content analysis 10:00 to 19:20 Digital kiosks Matilda Nottagee-posterPeople with mental disorders resulting in addiction to alcohol in Poland - legal aspects of medical, social assistance. 10:00 to 19:20 Digital kiosks Joanna Rajewska de Mezere-posterPersonality traits and recovery 10:00 to 19:20 Digital kiosks Elise Constance Fodstade-posterPilot implementation of a drug overdose reporting tool among Texas harm reduction organizations: A mixed methods study 10:00 to 19:20 Digital kiosks Jake Samorae-posterPiloting a strategy to prevent and manage alcohol-related problems in underage population at risk in health services 10:00 to 19:20 Digital kiosks Carla Filipa Bruguerae-posterPortuguese gym-goers versus Performance-enhancing Substances: What do we know? 10:00 to 19:20 Digital kiosks Ana Sofia Tavarese-posterPost-prison support for First Nations men in Australia and Canada 10:00 to 19:20 Digital kiosks Michael Doylee-posterPrevalence of BBD among PWID in treatment settings in Palestine between 2019-2023 10:00 to 19:20 Digital kiosks Abeer Habashe-posterPrevalence of substance use in Austrian prison systems 10:00 to 19:20 Digital kiosks Andrea Gampere-posterPrevention Matters: Towards a National Model of Prevention (within the National Programme on Illicit Drugs 2023 - 2030) 10:00 to 19:20 Digital kiosks Mateja Markle-posterPrevention of FASD in Luxembourg – a status report 10:00 to 19:20 Digital kiosks Jonathan Useldinge-posterProblematic Mobile Phone Use Related Changes in Topological Organization of Functional Brain Networks 10:00 to 19:20 Digital kiosks Lichang Yaoe-posterProcess indicators and outcomes of patients with SUD and Emotional Disorders: Comparison of pre-post COVID-19 pandemic 10:00 to 19:20 Digital kiosks Oscar M. Lozanoe-posterProfessional satisfaction and discontent: perspectives of health professionals on Addictive Behaviors and Dependencies 10:00 to 19:20 Digital kiosks Rita Valinhoe-posterProgram evaluation of a team-based approach addressing mental health and addictions in a Canadian urban centre 10:00 to 19:20 Digital kiosks Andrew Lodgee-posterProviding psychiatric services for hepatitis C virus patients with substance use disorders 10:00 to 19:20 Digital kiosks Anna Gorodetskye-posterPsilocin inhibits CYP450 metabolism of isoforms 2A6 and 3A4 10:00 to 19:20 Digital kiosks Andreia Machado Brito-da-Costae-posterPsychological Phenotypes in Glambling Disorder: A case study using the Pathway Model 10:00 to 19:20 Digital kiosks Ana Llorentee-posterPsychosocial and financial vulnerabilities in loot box purchasing: The mediating role of problem gambling 10:00 to 19:20 Digital kiosks Anu Sirolae-posterPsychosocial Determinants of Cannabis Protective Behavioral Strategies: Perceived Efficacy and Social Norms 10:00 to 19:20 Digital kiosks Fermin Fernández Calderóne-posterPsychosocial Factors Affecting Drug Relapse Among Youth in Pakistan 10:00 to 19:20 Digital kiosks Abdul Waheed Tabishe-posterPublic Health addressing illicit drug use and mental health disorders: Interinstitutional Community Intervention Group 10:00 to 19:20 Digital kiosks Paula Pinto Oliveirae-posterRecreational Cannabis and Social Media Use: A Correlational Cross-Sectional Study 10:00 to 19:20 Digital kiosks Roni Deli-Housseine-posterRecreational substance use and cognition in a large cohort of young adults with hair testing: Something is not nothing 10:00 to 19:20 Digital kiosks Lukas Eggenbergere-posterReitox National Focal Point Drug Monitoring System as a Model for Monitoring Other Addictions in Czechia 10:00 to 19:20 Digital kiosks Pavla Chomynovae-posterResilience and Sense of Coherence as Mediators in the Association between Problematic Mobile Phone Use and Depression 10:00 to 19:20 Digital kiosks Qi Daie-posterResults of İntegrated Bio-Behavioral surveillance among PWID in Azerbaijan 10:00 to 19:20 Digital kiosks Gunash Jafarovae-posterRhabdomyolysis in patients following opioid overdose 10:00 to 19:20 Digital kiosks Aleksandra Babulovskae-posterRiscos & Desafios Program: the students’ voice 10:00 to 19:20 Digital kiosks Gizela Rendoe-posterRisk of relapse to non-opioids among patients treated with XR-NTX or BP-NLX: A randomized clinical trial 10:00 to 19:20 Digital kiosks Arild Opheime-posterRisks and challenges of scaling up the intervention – an analysis of the program dissemination process 10:00 to 19:20 Digital kiosks Carla Rochae-posterRisky online behavior in relation to social support, depression and anxiety in Czech adolescents 10:00 to 19:20 Digital kiosks Terezie Babilonováe-posterRole of Psychiatric Nursing Staff in a Newly Founded Ward for Treatment of Adolescents Facing Addiction 10:00 to 19:20 Digital kiosks Aleš Zajce-posterSCHEMATIC FUNCTIONING AND EMOTIONAL REGULATION IN ALCOHOL DEPENDENCE: A CLINICAL AND NON-CLINICAL SAMPLE COMPARISON 10:00 to 19:20 Digital kiosks Ana Catarina Nunes da Silvae-posterSCIRe: Substance Consumption Informative Research - testing hair in electronic music festivals 10:00 to 19:20 Digital kiosks Ana Pegoe-posterScottish stakeholder views on closing the evidence to practice gap in substance use prevention 10:00 to 19:20 Digital kiosks Tara Shivajie-posterSelf-inflicted cut throat injuries and substance use during COVID-19: An analysis from Nepal 10:00 to 19:20 Digital kiosks Dipesh Bhattaraie-posterSelf-rated health among patients in opioid agonist therapy 10:00 to 19:20 Digital kiosks Jan Tore Daltveite-posterSleep dysregulation in alcohol use disorders. An exploratory study with a gender perspective. 10:00 to 19:20 Digital kiosks Ana Llorentee-posterSmartphone addiction and sexual distress: preliminary findings of a study in Portugal 10:00 to 19:20 Digital kiosks Pedro Campose-posterSmoking among people who use drugs 10:00 to 19:20 Digital kiosks Ingeborg Lunde-posterSocial work diagnosis and intervention in a harm reduction service for People Who Use Drugs 10:00 to 19:20 Digital kiosks Teresa Castroe-posterSpanish version of the Bergen Social Media Addiction Scale (BSMAS): validity, reliability and measurement invariance 10:00 to 19:20 Digital kiosks Conchita Sisi Martine-posterStigma and substance use disorders: a scoping review of patient and health care professionals’ attitudes. 10:00 to 19:20 Digital kiosks Ashlyn Schwartze-posterStigma by association among alcohol and other drug and harm reduction workers: Implications for workplace outcomes 10:00 to 19:20 Digital kiosks Theresa Caruanae-posterSubstance Use Among College Students in India: Necessity for Intervention 10:00 to 19:20 Digital kiosks Anju Dhawane-posterSubstance Use Treatment for non-speaker of the native language: Implications for migrants and the displaced 10:00 to 19:20 Digital kiosks Mayar Nawarae-posterSuicidal Behaviors and Alcohol Dependence: A Comprehensive Literature Review 10:00 to 19:20 Digital kiosks Marco Mota Oliveirae-posterSystematic analysis of Interventions for Opioid Use Disorder Among Adolescents 10:00 to 19:20 Digital kiosks Joye Anestise-posterSystematic review of recovery of neuropsychological function following abstinence in people with an Alcohol Use Disorder 10:00 to 19:20 Digital kiosks Anna Powelle-posterSystemic biases: Attitudes of correctional staff toward incarcerated people receiving opioid agonist treatment 10:00 to 19:20 Digital kiosks Joëlle Maguire-Le-posterTell me who you are, I'll tell you what to do: designing specific interventions for different types of gamers 10:00 to 19:20 Digital kiosks João Fariae-posterThe addiction nursing workforce empowerment - from international perspective to the national implementation and bac 10:00 to 19:20 Digital kiosks Vendula Pokornáe-posterThe association between alexithymia and binge drinking among young people 10:00 to 19:20 Digital kiosks Pelin Alpaye-posterThe association between psychological distress and alcohol consumption and physical activity 10:00 to 19:20 Digital kiosks Silvia Eiken Alperse-posterThe Autonomic Craving Signature: a biomarker of craving for personalized addiction treatment 10:00 to 19:20 Digital kiosks Marc Auriacombee-posterThe comparison and analysis of blood antioxidant levels in alcohol and drug addiction 10:00 to 19:20 Digital kiosks Nelly Sapojnikovae-posterThe Development of an Alcohol Strategy for the Northwest Territories, Canada 10:00 to 19:20 Digital kiosks Bryany Denninge-posterThe effect of Cue-induced Retrieval and Reconsolidation with Episodic Foresight on craving in opioid users receiving MMT 10:00 to 19:20 Digital kiosks Parnian Rafeie-posterThe effect of smoking cessation interventions on socioeconomic inequalities in smoking: A Cochrane systematic review 10:00 to 19:20 Digital kiosks Annika Theodouloue-posterThe effects of syringe service programs on overdose deaths in Tennessee 10:00 to 19:20 Digital kiosks Ryan Edgertone-posterThe Impact of psychotherapy on Comorbid Borderline Personality Disorder and Substance Use Disorder: A Systematic Review 10:00 to 19:20 Digital kiosks Manuel Jesús Ruiz Muñoze-posterThe impact of the tobacco law on hospitalizations due to the abusive consumption of psychoactive substances 10:00 to 19:20 Digital kiosks Filipe Pintoe-posterThe Intersection of Gambling with Smoking and Alcohol use in Great Britain: A Cross-Sectional Survey in October 2022 10:00 to 19:20 Digital kiosks Loren Kocke-posterThe Last Decade in Turkish Addiction Research: A Thesis-Based Analysis 10:00 to 19:20 Digital kiosks Belgin Varole-posterThe lived experience of persons receiving harm reduction services, finding an oasis in the deserted life of drug use 10:00 to 19:20 Digital kiosks Alexandros Tifase-posterThe Moral Improvisation of Harm Reduction in Abstinence Based Drug Policy Amongst Frontline Drug Workers in Hong Kong 10:00 to 19:20 Digital kiosks Katie Lowee-posterThe necessary adaptation of a public Therapeutic Community to new needs of the treatment process. 10:00 to 19:20 Digital kiosks Rita Fazenda Vieirae-posterThe potential of eHealth in the treatment of substance use disorders: a perspcitive on digital theraies 10:00 to 19:20 Digital kiosks André Almeidae-posterThe prevalence of cannabis use disorders in people who use medicinal cannabis: a systematic review and meta-analysis 10:00 to 19:20 Digital kiosks Danielle Dawsone-posterThe prevalence of Mental Health Disorders Among Cannabis Users 10:00 to 19:20 Digital kiosks Ada Hočevar Grome-posterThe prevalence, risk and protective factors of the co-morbidity of neurodiversity and substance use. 10:00 to 19:20 Digital kiosks Catherine Comiskeye-posterThe recovery of people with addictive behaviours and dependencies: intervention strategies of social workers 10:00 to 19:20 Digital kiosks Sara Carvalhoe-posterThe role of cartoon humor in the context of addictology efforts for the prevention of alcohol and tobacco use 10:00 to 19:20 Digital kiosks Linda Kočvarováe-posterThe role of coping in the association between cannabis use disorder and mental health; a one-year prospective study 10:00 to 19:20 Digital kiosks Nora de Bodee-posterThe role of COVID-19 in sleep quality and cognitive performance in alcohol–dependent patients 10:00 to 19:20 Digital kiosks Lea Kozinae-posterThe role of dissociative experiences in the link between psychological distress and Problematic Social Network Sites Use 10:00 to 19:20 Digital kiosks Simon Ghinassie-posterThe role of temperamental self-regulation in predicting treatment outcome in alcohol use disorders 10:00 to 19:20 Digital kiosks Els Santense-posterTHE ROLE OF WORK IN THE TREATMENT OF INDIVIDUALS RECOVERING FROM ADDICTION 10:00 to 19:20 Digital kiosks Farshad moshirie-posterThe Value of Outreach (VALOR): An evaluation of the implementation of alcohol assertive outreach in Greater Manchester 10:00 to 19:20 Digital kiosks Nikolaos Mylonase-posterTherapeutic Effects of Ayahuasca: The Psychological Processes Involved in the Relief of Depression and Grief. 10:00 to 19:20 Digital kiosks Mafalda Pinto Ribeiroe-posterTherapy of alcohol-dependent women serving prison sentences in Polish prisons 10:00 to 19:20 Digital kiosks Hanna Karaszewskae-posterThreat or opportunity: End-user perspectives on digital interventions for treatment of cannabis use 10:00 to 19:20 Digital kiosks Jasmin Lostedte-posterTraining Program for Self-management of Substance Addiction Consequences – a Randomized Controlled Trial Pilot Study 10:00 to 19:20 Digital kiosks Paulo Seabrae-posterTransgender and non-binary people's experiences with alcohol reduction in the UK: A cross-sectional study 10:00 to 19:20 Digital kiosks Dean Connollye-posterTREATMENT PROGRAMS FOR CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH MENTAL AND BEHAVIORAL DISORDERS DUE TO PAS USE 10:00 to 19:20 Digital kiosks Andrej Kastelice-posterTrilhos - Evaluation of a developmental prevention program 10:00 to 19:20 Digital kiosks Inês Abraãoe-posterTrust in healthcare providers for information about cannabis 10:00 to 19:20 Digital kiosks Meredith Meachame-posterTwenty years of integrated treatment of dual disorders in the netherlands: lessons learned 10:00 to 19:20 Digital kiosks Anneke van Wamele-posterUnderstanding Overdose Risk Perception in People who use Drugs - A Systematic Review 10:00 to 19:20 Digital kiosks Kerry B.D. Campbelle-posterUnmasking addictions: exploring the role of attributional styles 10:00 to 19:20 Digital kiosks Ana Tavarese-posterUse of CBD and low-THC products in North Macedonia 10:00 to 19:20 Digital kiosks Sanja Proshevae-posterUsing a digital client segmentation tool among clients with problematic substance use 10:00 to 19:20 Digital kiosks Ella Plaamie-posterUsing Functional Near Infrared Spectroscopy to Detect Neurocognitive Differences Across Social Drinking Patterns 10:00 to 19:20 Digital kiosks Rebecca Kuipere-posterVeterinary Drugs as Toxic Adulterating Substances in the Street Drug Supply 10:00 to 19:20 Digital kiosks Barry Logane-posterVoices of the unhoused from Santa Fe, New Mexico: health status, substance use, and community harm reduction views 10:00 to 19:20 Digital kiosks Laura Browne-posterWhen substance use disorder and eating disorder intersect: an integrated care tool. 10:00 to 19:20 Digital kiosks Zoya Barbiere-posterWillingness and Contextual Considerations for Supervised Consumption Sites among People Who Inject Drugs in Stockholm 10:00 to 19:20 Digital kiosks Elin Holméne-posterWorkforce development and co production as key enablers of successful service delivery. 10:00 to 19:20 Digital kiosks Martin Blakebroughe-posterWorking memory in context: the role of alcohol distractors in low to heavy alcohol drinkers 10:00 to 19:20 Digital kiosks Karis Colyer-Patele-posterWorking Towards Health and Wellness: The Infinite Pathways of Recovery 10:00 to 19:20 Digital kiosks Meghann Perrye-poster“To smoke feels gender”: A Photovoice Study of Cannabis Use Among Transgender and Non-Binary Youth 10:00 to 19:20 Digital kiosks Christian Barborini 11:50 Oral presentationNIDA International Program Research Update 11:50 to 13:20 Auditorium VI Tom ClarkeOral presentationManaging Benzodiazepine Dependence and High-Risk Use with Opiates: A feasibility study of a Co-produced Intervention 11:50 to 13:20 Auditorium II Catriona MathesonOral presentationTreatment of benzodiazepine withdrawal through taper dosing is most successful when it lasts less than 6 months. 11:50 to 13:20 Auditorium II Alert DrishtiOral presentationUnderstanding the research capacity of Australian alcohol and other drug services 11:50 to 13:20 Auditorium VI Robert StirlingOral presentationReport from LX24 side event - Strengthening networks and sharing innovation in practices on research and surveillance in the drugs field 11:50 to 13:20 Auditorium VI Vickna KasinatherCharles ParryOral presentationThe effectiveness of naloxone in reversing opioid overdose: The European naloxone outcome research study (NalPORS) 11:50 to 13:20 Auditorium II Nicola MetrebianShort communicationA systematic review of the nuances of attachment, bonding and parenting for mothers in addiction recovery 11:50 to 13:20 Room 1.07 Louise McCullochOral presentationAddiction and financial burden: Longitudinal 6-time point analysis of risk factors for debt enforcement in Finland 11:50 to 13:20 Room 5B Atte OksanenOral presentationBipolar disorder and severe poisoning due to medicines or illicit substances 11:50 to 13:20 Auditorium VII Aleksi HaminaShort communicationEmbodied Storytelling: An Accessible Approach to Re-storying in the Recovery Process 11:50 to 13:20 Room 1.07 Meghann PerryShort communicationEmotional dysregulation as a predictor of cocaine severity and withdrawal symptoms 11:50 to 13:20 Room 1.07 Alba Palazón-LlechaOral presentationEnhanced self-efficacy in HCV management: educating a multidisciplinary drug and alcohol workforce in Europe and Canada 11:50 to 13:20 Room 5C Emma DayOral presentationExploring Australian addiction workers' views on inclusive treatment for transgender and gender diverse (TGD) clients. 11:50 to 13:20 Room 5C Nic Robinson-GriffithShort communicationExploring Personal Strengths and Resources in Long-Term Substance Use Disorder Recovery: Insights from Lived Experience 11:50 to 13:20 Room 1.07 Myriam BeaulieuOral presentationFoundations of Prevention Science and Practice Curriculum: Providing Technical Assistance through Training 11:50 to 13:20 Room 5C Maria Paula Luna JimenezOral presentationGambling Disorder and Work Disability: A National Registry Study in Sweden 11:50 to 13:20 Room 5B Viktor ManssonOral presentationHazardous substance use and mental health among refugees in shared accommodations – a mixed-methods study 11:50 to 13:20 Auditorium VII Miriam LorenzOral presentationLisdexamfetamine in the treatment of methamphetamine dependence, a randomised controlled trial 11:50 to 13:20 Auditorium II Nadine EzardOral presentationModelling the wider socio-economic costs of problematic opioid use in the UK 11:50 to 13:20 Auditorium VIII George KeelOral presentationPrevalence of opioid dependence in Scotland, 2015-2020: results from a Multi Parameter Estimation of Prevalence model 11:50 to 13:20 Auditorium VIII Hayley JonesOral presentationProblem Gambling Among Criminal Sanction Clients: Project Overview 11:50 to 13:20 Room 5B Sari CastrénShort communicationRecovery does not stop at discharge: A qualitative evaluation of Alcohol Recovery Navigators in North East England. 11:50 to 13:20 Room 1.07 Emma-Joy HollandOral presentationScaling up Harm Reduction: Results of the 3-year Take-Home Naloxone project NALtrain in Germany. 11:50 to 13:20 Room 5C Simon FleißnerOral presentationSuicide-related service presentations following residential treatment for substance use disorders: a data linkage study 11:50 to 13:20 Auditorium VII Calvert TisdaleShort communicationThe effect of Individual Placement and Support on employment outcomes for individuals with substance use disorders 11:50 to 13:20 Room 1.07 Eline Borger RognliOral presentationThe impact of severe mental illness on treatment retention and all-cause mortality of people in opioid agonist treatment 11:50 to 13:20 Auditorium VII Nicola JonesOral presentationThe reciprocal effects of gambling expenditure and crime. 11:50 to 13:20 Room 5B Don WeatherburnShort communicationThe role of specialist substance use and addiction treatment in building recovery capital 11:50 to 13:20 Room 1.07 Florian De MeyerOral presentationTwenty-one years of heroin-related mortality in Australia: Joinpoint regression analysis of trends by age and gender 11:50 to 13:20 Auditorium VIII Amanda RoxburghOral presentationUnderestimate of deaths due to specific opioids in England and Wales for a decade 11:50 to 13:20 Auditorium VIII Shuoqi ChenShort communicationUnderstanding the process of drug addiction recovery through learning from lived experience 11:50 to 13:20 Room 1.07 Thomas Martinelli 14:20 Oral presentationWhy is a gender perspective needed in the drug field? Insight from the latest European drugs data. 14:20 to 15:50 Auditorium VIII Linda MontanariShort communicationAlcohol prevention: a review using Topic Modelling 14:20 to 15:50 Room 1.08 Nina HarthShort communicationAttention and reward related brain activity in cannabis users: A registered report of a longitudinal study 14:20 to 15:50 Auditorium III Inês MacedoShort communicationBarriers and Enablers in Disclosing Substance Use by Pregnant Women in Australian prisons 14:20 to 15:50 Room 1.06 So Bi KimOral presentationBridging the Gap: Exploring School Survey Data in Drug Policy and Prevention - Insights from the ESPAD-MedSPAD Project 14:20 to 15:50 Room 5A Elisa BenedettiShort communicationCannabis and mental health in Germany: a baseline estimation pre legalization 14:20 to 15:50 Room 1.08 Eva-Maria KrowartzShort communicationCognitive impairment as a predictor of long-term psychological distress in patients with polysubstance use disorders 14:20 to 15:50 Auditorium III Jens HetlandOral presentationDeveloping and operationalising a multi-component drug outreach service for young people aged 16-25 in England 14:20 to 15:50 Room 5A Zoe WelchShort communicationDigital Invisibility: Presence of Substance Use Disorder Treatment Programs for Women in the Caribbean 14:20 to 15:50 Room 1.06 Rocio Suarez OrdoñezShort communicationDoes lisdexamfetamine maintenance help or hinder cognitive function in people with current methamphetamine dependence? 14:20 to 15:50 Auditorium III Raimondo BrunoOral presentationDrug-induced homicide laws in the US: current trends, stakeholder opinions, and public health impacts 14:20 to 15:50 Auditorium VI Jennifer CarrollShort communicationEasy to reach, hard to research: cognitive function and substance use characteristics of people with severe drug use. 14:20 to 15:50 Auditorium III Nina AuestadShort communicationEvaluation of heroin-assisted treatment in Norway: Protocol for a mixed methods study 14:20 to 15:50 Room 1.08 Lars Henrik MyklebustOral presentationGender Compression Over Time in Measures of Cannabis Use by Age and Cohort in the United States 14:20 to 15:50 Auditorium VIII Michael VuoloOral presentationGlobal coverage of interventions to prevent and manage injecting drug use related harms in prisons: a systematic review 14:20 to 15:50 Auditorium VI Thomas Santo Jr.Short communicationIn favor or against the codependency concept: A narrative review of arguments in scientific literature 14:20 to 15:50 Room 1.08 Alexis Beaulieu-ThibodeauOral presentationJudge Demographics and Their Impact on Sentencing of Drug Crimes 14:20 to 15:50 Auditorium IV Sarah Henry DavisOral presentationLeximetric analysis of drug laws and evaluation of outcomes: cross-country analyses approach 14:20 to 15:50 Auditorium IV Carla RossiOral presentationMATPACT: An innovative approach to finding Scotland’s forgotten generation 14:20 to 15:50 Auditorium VI Marion GilliesOral presentationNavigating the Shift: Understanding the Dynamics of Cannabis Use in Germany Amidst Legalization Prospects 14:20 to 15:50 Auditorium IV Sally OlderbakShort communicationNeural Correlates of Addiction: A Resting-State Meta-Analysis of Substance Use Disorders and Behavioral Addictions 14:20 to 15:50 Auditorium III Marc RitterShort communicationNK1 antagonism modulates negative emotional processing in abstinent opioid dependent individuals and healthy controls 14:20 to 15:50 Auditorium III Lexi HandShort communicationPhosphatidylethanol as a screening tool for alcohol consumption during pregnancy 14:20 to 15:50 Room 1.06 Margareeta HäkkinenOral presentationPolicy and Practice Responses to Drug-Related Deaths: Governance issues in English and Welsh Prisons, 2015-2021 14:20 to 15:50 Auditorium VI Karen DukeShort communicationPrevalence and trends of ethanol and drugs among arrested drivers in Norway in the period 2013-2023 14:20 to 15:50 Room 1.08 Ragnhild JamtOral presentationRisk and protective factors in adolescents: adapting Communities that Care Youth Survey for Portuguese context 14:20 to 15:50 Room 5A Susana HenriquesOral presentationRisk factors for the gambling, smoking and alcohol consumption triad: an observational study in Portuguese adolescents 14:20 to 15:50 Room 5A Pedro RamosOral presentationSmoking and nicotine use behaviours among women of reproductive age: a ten-year population study in England 14:20 to 15:50 Auditorium VIII Sharon CoxShort communicationSocial Cognition in people with substance use disorders 14:20 to 15:50 Auditorium III Sónia RodriguesShort communicationThe bodily parallel: Bridging Gaps in Current Theories of Addiction and Interoception 14:20 to 15:50 Auditorium III Mateo Leganes-FonteneauOral presentationThe effects of legislative measures for 3-MMC in the Netherlands on drug sample composition and self-reported effects. 14:20 to 15:50 Auditorium IV Pieter OomenShort communicationThe important role of social connectedness in the alcohol use of women aged 50 to 62 years. 14:20 to 15:50 Room 1.06 Grainne ClarkeOral presentationThe perspective of transgender and non-binary people on their substance use trajectories and resilience processes 14:20 to 15:50 Auditorium VIII Abdelhakim MissoumShort communicationThe relationship between cannabis and tobacco use - a systematic review and meta-analysis 14:20 to 15:50 Room 1.08 Tesfa MekonenShort communicationTuning In for Chemistry: Setting up a multi-instrument mobile drug-checking lab at a 7-day psychedelic music festival 14:20 to 15:50 Room 1.08 Daniel MartinsShort communicationUtilization of pharmacological treatment for alcohol use disorder in pregnancy in the total Swedish population 14:20 to 15:50 Room 1.06 Sara Wallhed Finn 16:00 Oral presentationIncreased hepatitis C and HIV incidence among people who inject drugs in Montreal, Canada, 2011-2023 16:00 to 17:30 Auditorium IV Sarah LarneyKeynote presentationEvidence-based prevention through collaborative action? Opportunities and challenges for community-based participatory research in prevention science 16:00 to 17:30 Auditorium I Samuel TomczykKeynote presentationChallenges in community-based prevention 16:00 to 17:30 Auditorium I Harry SumnallKeynote presentationThe key components of CTC, including forming intersectoral coalitions, using a data-driven and needs-oriented approach to select evidence-based measures, and considering local contextual conditions during implementation. 16:00 to 17:30 Auditorium I Maximilian von HeydenKeynote presentationWhat do we (not) know about community-based prevention and how to move forward? 16:00 to 17:30 Auditorium I Ina KoningOral presentation"Boxing Clever Cork saved my life": an evaluation of an Irish early addiction recovery initiative 16:00 to 17:30 Auditorium III Rebekah BrennanShort communicationA mindfulness-based intervention for craving reduction in gambling and video gaming disorder: A case study. 16:00 to 17:30 Room 1.05 Francisco José Rivero RamónShort communicationA pilot program using Tabletop Role-Playing Games to reduce social anxiety and addiction symptoms in online gamers 16:00 to 17:30 Room 1.05 Joël BillieuxOral presentationA Safer Downtown for All: Including People Who Use Drugs in the Solutions to Social Disorder 16:00 to 17:30 Auditorium III Rob BoydShort communicationAccessibility, local socioeconomic disadvantage and expenditure on electronic gambling machines 16:00 to 17:30 Room 1.07 Jani SelinOral presentationAcute drug-toxicity presentations involving crack cocaine to Euro-DEN Plus sentinel hospitals in Europe from 2014-2022 16:00 to 17:30 Room 5A Isabelle GiraudonOral presentationAntipsychotics and relapse risk in persons with first-episode psychosis and co-occurring cannabis use disorder 16:00 to 17:30 Auditorium VII Heidi TaipaleShort communicationAssociations between mental health and substance use in higher education students in Germany – a cross-sectional study 16:00 to 17:30 Room 1.08 Robert HrynyschynOral presentationAssociations of alcohol consumption with long-term mortality of ART-naïve persons seeking HIV care. 16:00 to 17:30 Auditorium IV Daniel FusterShort communicationBarriers and facilitators for accessing HCV care in PWID: a qualitative study using an intersectional approach 16:00 to 17:30 Room 1.08 Ilhame AnwarShort communicationBarriers and facilitators to accessing drug treatment services for people who use drugs in Oman: a qualitative study. 16:00 to 17:30 Room 1.08 Oral presentationBuilding Capacity For Future Evaluation of Residential Treatment for People Experiencing Homelessness and Addiction 16:00 to 17:30 Auditorium III Ed AddisonOral presentationCannabinoid Use Experience among inpatients with psychotic symptoms – A Cross-Sectional study in a Portuguese Hospital 16:00 to 17:30 Auditorium VII Carolina Afonso RomanoOral presentationChallenges and support needs among persons with a migration background who use drugs in four metropolitan cities 16:00 to 17:30 Room 5C Wouter VanderplasschenOral presentationDecentralized consultation for infectious diseases with at-risk populations: preliminary results 16:00 to 17:30 Auditorium IV Paulo CaldeiraOral presentationDocumenting major shifts in methamphetamine and heroin prices and purity in metropolitan and rural Victoria, Australia 16:00 to 17:30 Auditorium VI Kasun RathnayakeOral presentationDrug markets and financial flows: underground banking in the Netherlands 16:00 to 17:30 Auditorium VI Nienke LiebregtsOral presentationDrug poisoning deaths of under 30-year-olds – Key issues in the cause of death investigation documents 16:00 to 17:30 Room 5A Sanna RönkäOral presentationDrug use and (non-)use of addiction treatment by women in French Guyana: gender and migration effects 16:00 to 17:30 Room 5C Estelle FilipeOral presentationEffects of recreational cannabis versus black market: A randomized controlled trial in Switzerland (WEED CARE) 16:00 to 17:30 Auditorium VI Lavinia BaltesShort communicationEfficacy assessment of the universal problem-gambling prevention program "What at stake?" 16:00 to 17:30 Room 1.05 Daniel Lloret-IrlesShort communicationEnvisioning youth-dedicated overdose prevention and drug consumption sites in Canada and Portugal 16:00 to 17:30 Room 1.08 Kali-olt SedgemoreShort communicationExploring the biopsychosocial needs of ageing heroin users in treatment in Malta: implications for service provision 16:00 to 17:30 Room 1.08 Anna GrechShort communicationExtended hours of video game play and negative physical symptoms and pain 16:00 to 17:30 Room 1.07 Janni LeungShort communicationFinancial hardship and gambling severity: a population-based study in Finland 16:00 to 17:30 Room 1.07 Tanja GrönroosShort communicationHarmful types of gambling: Changes and emerging trends in longitudinal helpline data 16:00 to 17:30 Room 1.07 Håkan WallOral presentationHow do purity and price of cocaine affect consumption in Austria? 16:00 to 17:30 Auditorium VI Birgit PriebeShort communicationLate relapse among ex-smokers using e-cigarettes following a quit attempt: a prospective one-year follow-up study 16:00 to 17:30 Room 1.08 Lion ShahabShort communicationMental health in people with hazardous cannabis and alcohol use - insights from a study of regulated cannabis sales 16:00 to 17:30 Room 1.08 Maximilian BuschnerOral presentationMigrants in the criminal justice system: A qualitative understanding of the role of substance use in their lives 16:00 to 17:30 Room 5C Marjolein De PauOral presentationMortality among first-time opioid agonist therapy patients in Austria, 2002-2021: A national retrospective cohort study 16:00 to 17:30 Room 5A Tanja SchwarzOral presentationMothers receiving substance use treatment involved in care proceedings: A record linkage cohort study 16:00 to 17:30 Room 5A Martha CanfieldShort communicationOnline Gambling Companies’ Interpretation of Duty of Care and its Implication for Responsibilisation of Gambling Related Harm 16:00 to 17:30 Room 1.07 Maria PerssonOral presentationPsychoactive Substance Use Among Russian Migrants Relocated to Georgia Following the 2022 Ukrainian Invasion 16:00 to 17:30 Room 5C David OtiashviliOral presentationReal-world effectiveness of antipsychotic medication in relapse prevention after cannabis-induced psychosis 16:00 to 17:30 Auditorium VII Antti MustonenOral presentationRefugees & drug use in Belgium: A national study on drug-related intervention needs in the reception setting (DrugInt) 16:00 to 17:30 Room 5C Charlotte de KockShort communicationReligiosity and gambling - moderating role of reflective thinking: A Polish-Georgian Study 16:00 to 17:30 Room 1.07 Rafał BartczukShort communicationSubstance induced psychosis among persons with concurrent mental health and substance use disorders under pandemic 16:00 to 17:30 Room 1.08 Jørgen G. BramnessShort communicationSuicide by people in contact with drug and alcohol services: a national study 2021 to 2022 16:00 to 17:30 Room 1.08 Patrick HorganOral presentationSuperiority and cost-effectiveness of Individual Placement and Support for people with alcohol and drug dependence 16:00 to 17:30 Auditorium III John MarsdenShort communicationThe influence of CBT based treatment and therapeutical contract guidelines on a problem gambler abstinence treatment 16:00 to 17:30 Room 1.05 Pedro HubertShort communicationThe long and winding road to gambling disorder treatment 16:00 to 17:30 Room 1.05 David HodginsShort communicationThe “Me and others” prevention program: impact evaluation in a sample of Portuguese adolescents 16:00 to 17:30 Room 1.05 Joana AlexandreShort communicationToward a classification of technology design features promoting potentially addictive online behaviors 16:00 to 17:30 Room 1.05 Maèva FlayelleShort communicationWhat increases the risk of problem gambling in adolescents? Findings from the Greek arm of the ESPAD study 16:00 to 17:30 Room 1.07 Alexandra PrimetiOral presentation“Into a whirlwind”: Navigating psychosis and anti-psychotic treatment among youth entrenched in an urban drug scene 16:00 to 17:30 Auditorium VII Trevor GoodyearOral presentation“They kicked me out of hospital twice”: barriers and facilitators accessing care with an injecting-related infection 16:00 to 17:30 Auditorium IV Samantha Colledge-Frisby 17:50 Oral presentation20-year trends in Australian methamphetamine-related deaths: An age–period–cohort–interaction analysis 17:50 to 19:20 Auditorium IV Oisin StronachOral presentationA Collaborative Approach to New Drug Identification in an Emerging Drug Early Warning System 17:50 to 19:20 Auditorium III Donna PapsunOral presentationAchieving universal health coverage of opioid agonist treatment in Norway: a cost-utility analysis 17:50 to 19:20 Room 5B Prayash ChaudharyShort communicationAdão e Eva II Project – HIV, Hepatitis and other STI’s prevention and screening among hard-to-reach populations 17:50 to 19:20 Room 1.05 Paulo AnjosOral presentationAN IMPLEMENTATION SCIENCE EVALUATION OF SCOTLAND’S FIRST HEROIN ASSISTED TREATMENT (HAT) FACILITY 17:50 to 19:20 Room 5B Andrew McAuleyShort communicationAre Australian pharmacists willing and prepared to offer Hepatitis C services? Findings from a representative sample 17:50 to 19:20 Room 1.05 Louisa PiccoShort communicationBeing Seen and Heard: Exploring the Relational Dimension of Heroin Assisted Treatment in Norway. 17:50 to 19:20 Room 1.06 Vegard HauklandOral presentationCodeine, oxycodone, and tramadol prescription prior to overdose deaths compared to toxicological findings 17:50 to 19:20 Auditorium IV Hilde EdvardsenOral presentationComorbidity of substance use disorders and other mental health disorders: towards a common European approach 17:50 to 19:20 Auditorium VII Marta TorrensShort communicationDeath after residential treatment for opioid use disorder among people using fentanyl 17:50 to 19:20 Room 1.06 Jan GryczynskiOral presentationEffects of cannabis use timing and formulation on sleep among young adults who report high-intensity alcohol use 17:50 to 19:20 Auditorium VII Elizabeth R. AstonOral presentationEmergence of semi-synthetic cannabinoids in Europe – a perspective from the European Union Early Warning System 17:50 to 19:20 Auditorium III Rachel ChristieOral presentationExamining Associations Between Alcohol and Cannabis Simultaneous and Concurrent Co-Use and Mental Health Outcomes 17:50 to 19:20 Auditorium VII Bradley ConnerShort communicationGlobal utilization trends for weekly/monthly injectable buprenorphine (CAM2038) in the treatment of Opioid Use Disorder 17:50 to 19:20 Room 1.06 Michael FrostShort communicationHCV antibody and RNA testing combined with nursing and peer-based outreach to enhance HCV testing and treatment among vulnerable groups 17:50 to 19:20 Room 1.05 Solange Mendes AscensãoOral presentationHeavy drinking among ‘sober generation’ youth: a longitudinal study 17:50 to 19:20 Room 5C Marit Edland-GrytShort communicationImproving the model of care pathway for HCV between the drug care centres and their referral hospitals in Catalonia. 17:50 to 19:20 Room 1.05 Elena Torrell -PedreiraShort communicationLooking under rocks: Skin infections in people who use drugs: a mixed-methods investigation in Wales 17:50 to 19:20 Room 1.05 Michelle HughesOral presentationMedical use of psychedelic substances: EUDA's monitoring of key developments 17:50 to 19:20 Auditorium VIII Alexander SöderholmOral presentationMonitoring intravenous drugs use in Spain through syringe residue analysis 17:50 to 19:20 Auditorium IV Carlos Pernas-FraguelaOral presentationMotivations for cocaine use: relation with drug use patterns, risks and how this informs prevention 17:50 to 19:20 Room 5C Eva BlommeOral presentationMotivations underlying co-use of benzodiazepines and opioids in the UK: a qualitative study 17:50 to 19:20 Room 5C Gaby VojtShort communicationOxycodone and Morphine use in hospitals and primary healthcare in Norway 2010-2021 17:50 to 19:20 Room 1.06 Eirik HaarrShort communicationPrevalence and microelimination of Hepatitic C in intravenous drug users - improving linkage to care 17:50 to 19:20 Room 1.05 Eva-Carina HeierOral presentationReduced health care utilization after entering opioid agonist treatment; change in mental and somatic health domains 17:50 to 19:20 Room 5B Thomas ClausenOral presentationRoute-Dependent Subjective Effects of Medical Heroin in HAT: Implications for Treatment Trajectories 17:50 to 19:20 Room 5B Silvana De PirroOral presentationSelf-therapeutic use of psilocybin, MDMA and ketamine among Dutch nightlife attendees. 17:50 to 19:20 Auditorium VIII Frederiek SchuttenShort communicationSTTBI risk reduction with OAT among people with prescription-type opioid use disorder 17:50 to 19:20 Room 1.05 M. Eugenia SociasOral presentationSynthetic cathinones in drug-related deaths – an alarming issue or triviality? 17:50 to 19:20 Auditorium III Ilkka OjanperäOral presentationThe relationship between self-reported childhood maltreatment and mental health in substance use disorders 17:50 to 19:20 Auditorium VII Aleksander Hagen ErgaOral presentationThe U.S. Psilocybin Landscape: Policy Evolution and Nationally Representative Insights 17:50 to 19:20 Auditorium VIII Beau KilmerOral presentationTrends in GHB use and harms in Australia 17:50 to 19:20 Auditorium III Rachel SutherlandShort communicationTrends in the detection and co-detection of drugs in a population attending opioid agonist treatment: 2010 to 2020 17:50 to 19:20 Room 1.06 Gráinne CousinsOral presentationWhat are the reasons for injecting methadone? A qualitative study among people who inject drugs in Barcelona 17:50 to 19:20 Auditorium IV Gabriela BarbagliaOral presentation‘Russian Roulette’: how do people who co-use benzodiazepines and opioids experience the absence of harm reduction? 17:50 to 19:20 Room 5C Hannah Poulter 19:30 DiscussionWhy are we not doing better at reducing drug-related deaths? 19:30 to 20:30 Auditorium I Thomas ClausenMarie Jauffret-RoustideKeith HumphreysPaul DietzeKatri Abel-Ollo Thu 24 Oct 11:50 Oral presentationLong-acting injectable buprenorphine for opioid use disorder: key findings from a longitudinal qualitative study 11:50 to 13:20 Auditorium IV Joanne Nealee-short communicationEnsuring Quality Care: community-led monitoring of client satisfaction and accessibility of OAT programs 11:50 to 13:20 Auditorium IV Maria PlotkoOral presentationAdapting Opioid Therapy: Transition from Methadone to Slow-Release Morphine Amid COVID-19 Supply Chain Disruptions 11:50 to 13:20 Auditorium IV Artūras BarkusOral presentationA Global Perspective on Treatment Service Provision for Opioid Use Disorders 11:50 to 13:20 Auditorium III Arash Khojasteh ZonooziOral presentationA Holistic Multi-Disciplinary Healthcare Pathway for Older Men who use Anabolic Androgenic Steroids 11:50 to 13:20 Room 1.08 Evelyn HearneShort communicationA scoping review of mass media interventions intended to reduce stigma towards people who use drugs 11:50 to 13:20 Auditorium VII Adam HollandOral presentationA wastewater-based approach to monitor shifting trends in illicit drugs consumption in Switzerland 11:50 to 13:20 Room 5A Livia AndraniOral presentationCannabis policy and practice in Finland: from social media discussions to citizens initiatives 11:50 to 13:20 Room 1.08 Aleksi HupliDiscussionChallenges, threats, and opportunities in addiction publishing today 11:50 to 13:20 Room 1.05 John MarsdenMatilda HellmanAnees BahjiBryon AdinoffShort communicationChanges in the use of non-prescribed hydromorphone and unregulated opioids use in Vancouver, Canada, 2018-2022 11:50 to 13:20 Auditorium VII Kanna HayashiOral presentationClinicians’ experience of providing heroin-assisted treatment: Key rewards and challenges 11:50 to 13:20 Room 5C Rune EllefsenShort communicationDefinition of public amenity in drug consumption room literature: A scoping review 11:50 to 13:20 Auditorium VII Bianca WhitesideOral presentationDrugs and climate change: knowledge gaps in monitoring environmental impacts of drugs 11:50 to 13:20 Room 1.08 Tim SurmontShort communicationEnhancing Harm Reduction: A Qualitative Evaluation of Athens' Drug Consumption Room 11:50 to 13:20 Auditorium VII Benjamin ScherOral presentationEuropean Hair Drug Analisys Network – A pioneer study to investigate the use of NPS and NSO 11:50 to 13:20 Room 5A Elisa ForneroOral presentationFostering Community: A Mixed Method Analysis of Kosmicare's Mobile Drug Checking Service in Lisbon, Portugal 11:50 to 13:20 Room 5C Helena ValenteOral presentationHealth-related quality of life trajectories of patients in heroin-assisted treatment 11:50 to 13:20 Auditorium III Francesca MelisOral presentationImpact of long-acting depot buprenorphine post-release from custody– Early findings from the Release Study 11:50 to 13:20 Auditorium IV Adrian DunlopOral presentationKey challenges for alcohol epidemiology and alcohol control policy evaluation 11:50 to 13:20 Auditorium VI Jürgen RehmOral presentationLegally grey? Drug checking perspectives in the CEECA region 11:50 to 13:20 Auditorium VI Eliza KurcevičOral presentationOpioid disorder treatment outcomes — the OPTIMUS international consensus on evidence-based and patient-centred care 11:50 to 13:20 Auditorium III Lucas WiessingShort communicationOverdoses in the drug consumption room in Oslo: route of administration matters! 11:50 to 13:20 Auditorium VII Desiree EideOral presentationPerceptions of family physicians in Istanbul on e-cigarettes as smoking cessation aids 11:50 to 13:20 Room 1.08 Melis SelamogluOral presentationPrevention of hazardous substance use among refugees – digital tools for the workforce in refugee aid 11:50 to 13:20 Room 5C Jonathan UricherOral presentationPublic health for whom? Unpacking the assumptions and silences in Canada's public health approach to substance use. 11:50 to 13:20 Auditorium VI Sophie HendersonShort communicationReasons for (non-)using a drug consumption room: the point of view of drug users. 11:50 to 13:20 Auditorium VII Sanda SamitcaShort communicationSafe Inhalation Pipe Provision Study: Intervening to improve policy and practice for people who use crack in England. 11:50 to 13:20 Auditorium VII Magdalena HarrisOral presentationSynthesis of multisource data for the development of an advanced dashboard to monitor illicit drugs markets 11:50 to 13:20 Room 5A Pierre EsseivaOral presentationThe Costs and Harms of Substance Use in Canada: Key Trends from 2007 to 2022 11:50 to 13:20 Auditorium VI Pam KentOral presentationThe situation of Harm Reduction in Spain: a qualititive approach incluying PWUD 11:50 to 13:20 Room 5C Ester ArandaShort communicationThe Value of Peer Research: A Peer Perspective 11:50 to 13:20 Auditorium VII Christos AnastasiouOral presentationTrends in use of medicines for opioid agonist treatment in Australia, 2013–2022 11:50 to 13:20 Auditorium III Michael FarrellOral presentationWhat can Portugal do to prevent be caught off guard again in the drug domain? 11:50 to 13:20 Room 5A Alcina Correia 14:20 Short communicationMaking a case for health promotion theoretically underpinned policies and practices around alcohol in workplace settings 14:20 to 15:50 Room 1.06 Lolita AlfredShort communicationIntroducing the European Prevention Curriculum (EUPC) in Austria – findings from a pilot implementation 14:20 to 15:50 Room 1.06 Martin BuschShort communicationAdvancing Science-Based Prevention: Insights from the EUPC Training in Bosnia and Herzegovina 14:20 to 15:50 Room 1.06 Amir HasanovicShort communicationPiloting EUPC Training in the Republic of Georgia: Lessons Learned 14:20 to 15:50 Room 1.06 Jana D. JavakhishviliShort communicationTRAINING ON THE EUROPEAN PREVENTION CURRICULUM (EUPC) FOR DOPs- THE CYPRIOT EXPERIENCE 14:20 to 15:50 Room 1.06 Maria MatheouShort communicationThe Frontine Politeia project: the need for involving prevention implementers within substance use and crime prevention 14:20 to 15:50 Room 1.06 Annemie CooneOral presentationDynamic associations between anxiety and alcohol use from early adolescence to young adulthood. 14:20 to 15:50 Auditorium VII Margot PeetersShort communicationStrengthening the capacity and agency of drug prevention stakeholders on the key issue of evidence-based prevention. 14:20 to 15:50 Room 1.06 Rachele DoniniOral presentationA mixed methods systematic review of interventions for women in the perinatal period, who are dependent on drugs 14:20 to 15:50 Room 5B Emma SmithShort communicationA multisite implementation trial of collaborative care for Opioid Dependence: 3-month outcomes from the EPIC-MATOD trial 14:20 to 15:50 Room 1.05 Suzanne NielsenOral presentationA randomized controlled trial of support programs for parents of treatment-refusing substance using young adults 14:20 to 15:50 Auditorium VII Ola SiljeholmShort communicationA socio-ecological systematic review of harm reduction interventions addressing the U.S. opioid overdose epidemic 14:20 to 15:50 Room 1.05 Katie McCormickShort communicationAn economic evaluation of Catalonia’s Needle Exchange Programme (NEP). Cost-Benefit analysis 14:20 to 15:50 Room 1.05 Asier Narbarte ArzuagaOral presentationAssociations between opioid agonist therapy exposure and chronic pain characteristics among people who inject drugs 14:20 to 15:50 Auditorium IV Sasha UdhesisterOral presentationCannabis use disorder and the brain: The role of cross-cultural differences in cannabis attitudes 14:20 to 15:50 Auditorium III Janna CousijnOral presentationCommunity-wide effects of building a resilient community healthcare workforce 14:20 to 15:50 Room 5C Carol JonesOral presentationDifferential effects of left and right insula inhibition on craving and cognitive control in regular smokers 14:20 to 15:50 Auditorium III Mieke SchulteOral presentationDrug-related deaths among housed and homeless individuals in the UK and the USA 14:20 to 15:50 Auditorium IV Emmert RobertsOral presentationDrug-related mortality associated with gabapentinoid/Z-drug co-prescribing among opioid-agonist treatment recipients 14:20 to 15:50 Auditorium IV Megan GlancyShort communicationEffect of integrated smoking cessation treatment on smoking intensity among persons who receive opioid agonist treatment 14:20 to 15:50 Room 1.05 Karl Trygve Druckrey-FiskaaenShort communicationEmpowering Global Drug Prevention: A Systematic Approach 14:20 to 15:50 Room 1.06 Ali YassineOral presentationEXPERIENCES OF DRUG CONSUMPTION ROOM PROFESSIONALS 14:20 to 15:50 Room 5C Patricia Domingos BeloOral presentationFemale-specific trends and treatment needs for substance use disorder among homeless and at-risk females 14:20 to 15:50 Room 1.08 Anne Marie CarewOral presentationGender and drugs: Experiences of stigma/toxicophobia and narcofeminist narratives 14:20 to 15:50 Room 1.08 Marie Jauffret-RoustideOral presentationHigh body mass index is prevalent in people with opioid use disorder in Northern England and increases risk of death 14:20 to 15:50 Auditorium IV Caroline CopelandShort communicationHomeless people and mental health: an observational study in an Emergency Shelter in Lisbon 14:20 to 15:50 Room 1.05 Gonçalo HenriquesOral presentationInnovation in caring for individuals experiencing polydrug use disorder: opportunities to understand multi-morbidities 14:20 to 15:50 Room 5C Alexander BaldacchinoShort communicationMulti Parameter Estimation of Prevalence modelling: methods to estimate the prevalence of opioid dependence in Scotland 14:20 to 15:50 Room 1.05 Andreas MarkoulidakisOral presentationPeripheral endocannabinoids and related lipids in individuals with chronic non-medical prescription opioid use 14:20 to 15:50 Auditorium III Sara KrollOral presentationPolicy Responses to Drug-Related Deaths: The power of numbers? 14:20 to 15:50 Auditorium IV Lena ErikssonOral presentationPregnancy-related hospitalisation among women who inject drugs in Melbourne, Australia 14:20 to 15:50 Room 5B Ashleigh StewartOral presentationSubstance use variation among LGBTQ+ youth: stress, resilience and ecosystemic intervention 14:20 to 15:50 Auditorium VII Julie-Christine CottonOral presentationThe care pathways of women who use drugs in the perinatal period. Findings of a qualitative, longitudinal study 14:20 to 15:50 Room 5B Polly RadcliffeOral presentationThe genetic etiology of cannabis use: from twin models to genome-wide association studies and beyond 14:20 to 15:50 Auditorium III Karin J. H. VerweijOral presentationThe perinatal period as a window of opportunity for change and recovery? A study of mothers and relatives' accounts 14:20 to 15:50 Room 5B Sarah VandewalleShort communicationTreatment pathways and transitions of young adults during opioid maintenance treatment 14:20 to 15:50 Room 1.05 Sanna IivonenOral presentationUnderstanding substance use and affective symptoms in late adolescents in an urban context: A network approach 14:20 to 15:50 Auditorium VII Helle LarsenOral presentationUnveiling the Nexus of Addiction, Violence, and Risk: Generational Patterns in Female Populations 14:20 to 15:50 Room 1.08 Sabrina MolinaroOral presentationVulnerabilities and agencies of women who use and sell drugs in Bordeaux and Montréal 14:20 to 15:50 Room 1.08 Sarah PerrinOral presentationWhat do clinicians think about psychedelic assisted therapy? An Australian perspective. 14:20 to 15:50 Room 5C Zachary Bryant 16:00 Oral presentationA comparative analysis of state-controlled models for legal cannabis sales in Uruguay and Quebec (Canada) 16:00 to 17:30 Auditorium VI Marta RychertOral presentationA provisional evaluation of Australia’s medical cannabis framework 16:00 to 17:30 Auditorium VI Myfanwy GrahamOral presentationAdverse childhood experiences and drug use in early adulthood: an analysis of the Growing Up in Ireland 1998 cohort 16:00 to 17:30 Room 5A Deirdre MonganOral presentationBiography, age and temporality: understanding shifts in alcohol consumption over time among young abstainers 16:00 to 17:30 Room 5A Amy PennayOral presentationBrorphine analogues as new psychoactive substances: in vitro and in vivo pharmacological characterization 16:00 to 17:30 Auditorium III Marthe VandeputteOral presentationConsequences of cannabis legalization on use and health outcomes on the basis of international experiences 16:00 to 17:30 Auditorium VI Uwe VertheinOral presentationFactors associated with cocaine use in late adolescence and young adulthood in the Growing Up in Ireland cohort study 16:00 to 17:30 Room 5A Margaret BrennanOral presentationIn vitro cannabinoid activity-based screening of seized plant materials: a future-proof harm reduction strategy? 16:00 to 17:30 Auditorium III Axelle TimmermamnOral presentationNeurotoxicity of synthetic cathinones: Can metabolism play a role? 16:00 to 17:30 Auditorium III Alexandra AntunesOral presentationOnline Addictions Expert Group of the Pompidou Group: Results and Recommendations 16:00 to 17:30 Room 5B Jann SchumacherOral presentationPharmacology of 30 semisynthetic cannabinoids – and why details matter when assessing the harm potential of seized drugs 16:00 to 17:30 Auditorium III Christophe StoveOral presentationPrevention when exclusion is lifted: Intervention models from the New Swiss Gambling Act 16:00 to 17:30 Room 5B Linda EleziOral presentationRisks and harms associated with online gaming and gambling 16:00 to 17:30 Room 5B Eduarda FerreiraOral presentationSame Intentions, Different Outcomes: Divergent Paths and Implementation Gaps in Cannabis Legalization in North America 16:00 to 17:30 Auditorium VI Ivana ObradovicOral presentationThe end of responsible gambling 16:00 to 17:30 Room 5B Charles LivingstoneOral presentationWho is driving under the influence of cannabis in Germany? Findings of a large-scale online survey 16:00 to 17:30 Room 5A Anna Schranz 17:50 Oral presentationEpidemiology of injecting drug use and injection related harms among people who are incarcerated 17:50 to 19:20 Auditorium IV Louisa DegenhardtShort communicationA comparison of sales regulations across three types of cannabis dispensaries: First insights from the 'Züri Can' study 17:50 to 19:20 Room 1.06 Nadine HeckelOral presentationCocaine use on the rise – are politicians and city level services prepared for the emerging trend of crack cocaine? 17:50 to 19:20 Auditorium III Else Kristin Utne BergOral presentationContext specific factors that impact on the optimal scale up of hepatitis C testing and treatment in the UK 17:50 to 19:20 Auditorium IV Peter McCullochShort communicationDesigning an online training course for professionals dealing with pornography use and sexual dysfunctions 17:50 to 19:20 Room 1.07 Mary SharpeOral presentationDual diagnosis and their care pathways for help-seeking: a multi-center study from India 17:50 to 19:20 Auditorium VII Abhishek GhoshShort communicationExploring exposure to drug-related content on social media among youth and a pilot of drug prevention on TikTok 17:50 to 19:20 Room 1.07 Martha de JongeShort communicationHappy, healthy smartphone use: A participatory action research to improve higher education students’ mental well-being 17:50 to 19:20 Room 1.07 Madelief HartenOral presentationImpact of mental health on retention in OAT 17:50 to 19:20 Auditorium VII Lucy Thi TranOral presentationIntervention development of a nature-based programme for co-occurring mental health and substance use problems. 17:50 to 19:20 Auditorium VII Wendy MastertonShort communicationIs attentional absorption a risk factor for smartphone addiction? 17:50 to 19:20 Room 1.07 Rui Miguel CostaOral presentationIslands in the stream: The accessibility of mental health care for persons with substance use problems in Belgium 17:50 to 19:20 Auditorium VII Clara De RuysscherOral presentationIt is time to take nitrous oxide seriously 17:50 to 19:20 Room 5C Julaine AllanShort communicationLoneliness in the Digital Age:Role of Loneliness in Online Self-Verification and Social Media Addiction in Six Countries 17:50 to 19:20 Room 1.07 Iina SavolainenShort communicationManaging the drug-driver: insights from Victoria’s large-scale roadside testing program 17:50 to 19:20 Room 1.06 Michael FitzharrisShort communicationMetabolite profile of synthetic cannabinoids seized in Portugal 17:50 to 19:20 Room 1.06 Rita Padinha LopesOral presentationMisuse of psychoactive medicines and its harmful consequences in Portugal 17:50 to 19:20 Auditorium VIII Ana AraújoOral presentationNangs in Australia: Investigating nitrous oxide use among people who regularly use MDMA and/or other illicit stimulants 17:50 to 19:20 Room 5C Jodie GriggOral presentationNew challenges for outpatient care: trends from twenty years of monitoring treatment demand in the city of Hamburg 17:50 to 19:20 Room 5C Marcus MartensOral presentationPopulation aging and apparent decline in initiation of injecting drug use in Australia 17:50 to 19:20 Room 5C Olivia PriceShort communicationPresentation of a National Observatory for Internet and Gaming Addiction in Greece 17:50 to 19:20 Room 1.07 Georgios FlorosShort communicationProcrastination and Problematic Social Network Sites Use in adolescents: a serial mediation model 17:50 to 19:20 Room 1.07 Sara Bocci BenucciShort communicationProject on fine default prisoners with substance abuse problems – preliminary findings of an evaluation and impact study 17:50 to 19:20 Room 1.06 Jukka LeinonenShort communicationRecommendations from the government cannabis committee on the legal availability of vaping products. 17:50 to 19:20 Room 1.06 Robert PerreaultOral presentationResponding to the identification of nitazenes within the illicit diazepam market 17:50 to 19:20 Auditorium III Josie SmithShort communicationRisk factors for the social networking sites addiction: a systematic review 17:50 to 19:20 Room 1.07 Susanna PuigcorbéOral presentationSocioeconomic risk factors for long-term prescription opioid use: A national registry-linkage study 17:50 to 19:20 Auditorium VIII Ingvild OdsbuOral presentationThe development of a toolkit to support the elimination of viral hepatitis B and C in prisons 17:50 to 19:20 Auditorium IV Erika DuffellShort communicationThe experience of aging among patients in opioid assisted treatment. A qualitative study. 17:50 to 19:20 Room 1.06 Siv-Elin Leirvåg CarlsenShort communicationThe impact of Cannabis market Regulation on adolescents in Uruguay 17:50 to 19:20 Room 1.06 Leticia KeuroglianOral presentationTowards elimination of hepatitis C in Oslo: cross-sectional prevalence studies in 2018, 2021, 2022 and 2023 17:50 to 19:20 Auditorium IV Eirik OpheimOral presentationUnderstanding Drug Use in a Dutch Prison: A Call for Improved Research and Care and Lessons learned 17:50 to 19:20 Auditorium III Daan van der GouweOral presentationUsing intensive longitudinal data to investigate predictors of cannabis and opioid use among patients with chronic pain 17:50 to 19:20 Auditorium VIII Johannes ThrulOral presentationWords vs. strands: Does the concordance of self-reported and hair-analyzed substance use of young adults change over time? 17:50 to 19:20 Auditorium III Clarissa Janousch Fri 25 Oct 11:50 Oral presentationSituation in Afghanistan: Opium cultivation and heroin production 11:50 to 13:20 Auditorium I Angela MeOral presentationSubstance use patterns among young homicide offenders in Finland 2002-2022 11:50 to 13:20 Auditorium VIII Anna RaesteOral presentationHomicides committed by criminal groups involved in Swedish drug distribution 11:50 to 13:20 Auditorium VIII Kim MoellerOral presentationOpium and heroin production in Southeast Asia 11:50 to 13:20 Auditorium I Bryce PardoOral presentationAn exploration of drug market, gun violence and sociodemographic patterns in Stockholm Sweden and the prediction of gun violence 11:50 to 13:20 Auditorium VIII Mia-Maria MagnussonOral presentationImplications of heroin shortages in Europe: the emergence of synthetic opioids 11:50 to 13:20 Auditorium I Joanna MoraisOral presentationRevisiting Goldstein: A New Framework for Understanding Drug-Related Violence in a Globalised Era 11:50 to 13:20 Auditorium VIII Marieke LiemOral presentationThe evolving situation with nitazenes in Ireland 11:50 to 13:20 Auditorium I Eamon KeenanShort communication#What´sUP_TuDecides – Healthy Influencer of Internet and Gaming Use 11:50 to 13:20 Room 1.06 Carla AndradeOral presentationAccidental versus intentional drug overdose deaths: a national register linkage study 11:50 to 13:20 Auditorium IV Rebecca McDonaldShort communicationAn action plan for synthetic opioids - The Zurich approach 11:50 to 13:20 Room 1.05 Dominique SchoriOral presentationAn online survey of cannabis users and ex-users in Ireland 11:50 to 13:20 Room 5B Philip JamesOral presentationBehind the frontlines: Exploring mental well-being and burnout among harm reduction workers 11:50 to 13:20 Room 1.07 Katie McCormickShort communicationCommunity attitudes towards sanction and health-based interventions for individuals caught drug-driving in Australia 11:50 to 13:20 Room 1.05 Sara LiuOral presentationCurrent perspectives on the research and medical use of psychedelic drugs for alcohol addiction treatment 11:50 to 13:20 Auditorium VI Anton Gomez-EscolarOral presentationDevelopment and validation of the Problematic Dating App Use Scale (PRODAS): First results from a sexual minority cohort 11:50 to 13:20 Auditorium III Babette Lea WinterShort communicationDevelopment of an evidence-based classification framework for psychoactive substances in the illicit drug market 11:50 to 13:20 Room 1.05 Michèle Boileau-FalardeauOral presentationDo Self-Report Drug Use Surveys Produce the Same Results in Print and Online Mode? Findings from a Dual Mode Survey. 11:50 to 13:20 Room 5B Stelios StylianouOral presentationDrug use in French prisons. Results of the ESSPRI survey 11:50 to 13:20 Room 5C Caroline ProtaisOral presentationDrug-induced deaths and non-fatal poisonings in youth – associations with ACE and psychiatric morbidity 11:50 to 13:20 Auditorium IV Karoliina KarjalainenShort communicationExploring characteristics of videogame use and mental health in expert and casual female gamers 11:50 to 13:20 Room 1.06 Roxanne Hébert-RattéShort communicationGabapentinoids in Ireland (2010-2020): trends in prescribing, law enforcement drug seizures & post-mortem toxicology 11:50 to 13:20 Room 1.05 Gráinne CousinsOral presentationIllegal loot box advertising on social media: an empirical study using the Meta and TikTok ad transparency repositories 11:50 to 13:20 Auditorium III Leon Y. XiaoShort communicationIncreasing availability and production of synthetic cathinones in Europe – a perspective from the EU EWS 11:50 to 13:20 Room 1.05 Gregorio PlanchueloShort communicationMDMA misinformation: what dealers claim versus the actual MDMA content in ecstasy pills in the netherlands 11:50 to 13:20 Room 1.05 Lavinia StegemannShort communicationMedia portrayal of sports betting in Canada before and after Bill C-218 11:50 to 13:20 Room 1.06 Luke ClarkShort communicationNew research unit provides evidence to address national addictions policy challenges 11:50 to 13:20 Room 1.05 Leonie BroseOral presentationOnline approach and characteristics of the hidden population with substance use disorder that doesn’t reach treatment 11:50 to 13:20 Room 5B Ilias ParaskevopoulosOral presentationOverdoses in Healthcare Workers: A thematic framework analysis of coroner reports 11:50 to 13:20 Room 1.07 Thikra AlgahtaniOral presentationPredictors of untreated remission of Internet Use Disorder in a sample of adolescents and young adults 11:50 to 13:20 Auditorium III Lasse SchmidtOral presentationPrevalence of Benzodiazepine Prescription Prior to Overdose Deaths Compared to Toxicological Findings 11:50 to 13:20 Auditorium IV Anna Armika Tussilago NymanOral presentationPrison-based treatment needs for people with a history of substance use disorder: A nationwide cohort study 11:50 to 13:20 Room 5C Birgitte ThylstrupOral presentationPsychedelic therapy in the treatment of addiction: the past, present and future 11:50 to 13:20 Auditorium VI Rayyan ZafarOral presentationRelationship between parenting styles and problematic Internet use 11:50 to 13:20 Auditorium III Antonio RayaShort communicationSex differences in gaming disorder: Implication for a comprehensive treatment in lower-middle income country 11:50 to 13:20 Room 1.06 Kristiana SisteOral presentationSubstance use and psychological states in imprisoned population in Greece—Key findings from a recent nationwide survey 11:50 to 13:20 Room 5C Ioulia BafiOral presentationSuicide in people prescribed opioid-agonist therapy (OAT) in Scotland, 2011-2020: a national retrospective cohort study. 11:50 to 13:20 Auditorium IV Rosalyn FraserShort communicationThe comparison of gaming and gambling in relation to decision-making behavior and implicit associations 11:50 to 13:20 Room 1.06 Nanne DominickShort communicationThe emergence of nitazenes on the Irish heroin market: Lessons learned and challenges moving forward 11:50 to 13:20 Room 1.05 Nicki KilleenShort communicationThe Football Fans and Betting Project – Findings from an early intervention for male sports bettors 11:50 to 13:20 Room 1.06 Blair BiggarOral presentationThe Mental Health Challenges Faced by Harm Reduction Staff 11:50 to 13:20 Room 1.07 Laoise DarraghOral presentationThe old kid in the block: Unpacking signals of increased availability and use of ketamine 11:50 to 13:20 Auditorium VI Rita JorgeOral presentationThe Pharmacological Management of Ketamine Use Disorder: A Systematic Review 11:50 to 13:20 Auditorium VI Emmert RobertsDiscussionThe ripple effect: International developments in the opioid market and their potential implications for European public health and security 11:50 to 13:20 Auditorium I Steve TaylorOral presentationVicarious Trauma Among Nurses Working in Addiction Services and the Role of Leadership: A European Mixed Methods Study 11:50 to 13:20 Room 1.07 K. Nicki AnnunziataShort communicationVideo gaming in older adults: Resilience to impairment 11:50 to 13:20 Room 1.06 Daniel StjepanovicShort communicationVideo gaming: observational, genetic, and causal associations with cognition and health 11:50 to 13:20 Room 1.06 Joelle PasmanOral presentationWhat can we learn about poly-drug use among frequent cannabis users? results from the European Web Survey on Drugs 11:50 to 13:20 Room 5B Davide Fortin 14:20 Oral presentationUpdate on the situation in the Netherlands (tbc) 14:20 to 15:50 Auditorium VIII Margriet Van LaarOral presentationWork related cocaine use: prevalence and interventions 14:20 to 15:50 Auditorium II Marie-Claire LambrechtsOral presentationCannabis law reform in Switzerland: purpose, opportunities, and risks of local pilot projects 14:20 to 15:50 Auditorium VIII Frank ZobelOral presentationIssues of transport, driving safety & intoxication for opioid agonist treatment clients in New South Wales, Australia 14:20 to 15:50 Auditorium VI Daniel WinterOral presentationThe Workplace as a “Co-Therapist” 14:20 to 15:50 Auditorium II Camilla Lynne BakkengOral presentationCannabis law reform in Germany: a rocky road to a partial legalisation 14:20 to 15:50 Auditorium VIII Jakob MantheyOral presentationIndividual agreements for recovery from substance misuse. Employees’ response and experience of regulatory aspects. 14:20 to 15:50 Auditorium II Marianne LundOral presentationPhysical conditions and associated health service utilization among individuals with substance-related disorders 14:20 to 15:50 Auditorium VI Christophe HuỳnhOral presentationA healthy work environment for Eastern European migrant workers in The Netherlands 14:20 to 15:50 Auditorium II Desirée SpronkOral presentationCannabis law reform in Luxembourg: first observations after its change among recreational cannabis users and non-users 14:20 to 15:50 Auditorium VIII Nadine BerndtOral presentationThe effect of substance use disorders on vaccine uptake, acceptance, and adherence: a global systematic review 14:20 to 15:50 Auditorium VI Eva Maria HavelkaOral presentationOut of treatment drug and alcohol users in England: ‘Unmet Treatment Need’? 14:20 to 15:50 Auditorium VI Charlie LloydOral presentationPathways into individual substance misuse recovery agreement in the workplace 14:20 to 15:50 Auditorium II Janne ScheffelsOral presentationAddressing Alcohol-Related Risks among Individuals with Disabilities in Sports: A Swiss Perspective 14:20 to 15:50 Room 5A Nikolai KiselevOral presentationAre Take-Home Naloxone kits available at witnessed overdose events - a European Naloxone Outcome Research Study 14:20 to 15:50 Auditorium IV Teodora DascalOral presentationCulturally safe addiction services: An integrated circle of care for homeless Indigenous peoples in Montréal, Canada 14:20 to 15:50 Room 5A Jessica NeicunOral presentationDevelopment, implementation and liquidation of a national Danish Train-the-Trainer system 2010 - 2023 14:20 to 15:50 Auditorium IV Henrik ThiesenOral presentationEvaluating a pilot intervention development programme utilising respiratory monitoring to prevent drug-related deaths 14:20 to 15:50 Auditorium IV Kristina HnízdilováOral presentationImpact of Precursor Control on Drug Markets: An Expanded and Updated Systematic Review 14:20 to 15:50 Room 5B Luca GiommoniOral presentationInterventions to reduce harms related to drug use among people who experience incarceration: A systematic review 14:20 to 15:50 Auditorium VII Christel MacdonaldOral presentationPRS20: drug use and perceived mental health concerns among people living in prison in the Grand-Duchy of Luxembourg 14:20 to 15:50 Auditorium VII Tom KugenerOral presentationRadio theater-based prison artistic intervention: a mixed-method evaluation 14:20 to 15:50 Auditorium VII Isabel SilvaOral presentationSpatial analysis of drug seizure events in the Golden Triangle: Findings from UNODC’s Drug Monitoring Platform 14:20 to 15:50 Room 5B Bryce PardoOral presentationSubstance Use, Well-being, and Spiking among LGBTIQ+ and Non-LGBTIQ+ Nightlife Patrons: A Cross-Sectional Survey 14:20 to 15:50 Room 5A Ruben van BeekOral presentationThe impact of the 2022 ban on drug production in Afghanistan 14:20 to 15:50 Room 5B Angela MeOral presentationThe impacts of cannabis legalization in the Americas: Insights from a systematic review 14:20 to 15:50 Room 5B Elle WadsworthOral presentationThe multidimensional needs and integrated service utilization patterns of youth using non-medical prescription opioids 14:20 to 15:50 Room 5A Kirsten MarchandOral presentationWho reports witnessing an opioid overdose? : Findings from the European naloxone outcome research study (NalPORS) 14:20 to 15:50 Auditorium IV Clare Mackie